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Abstract 28 
In the hippocampus, estrogens are powerful modulators of neurotransmission, synaptic plasticity and 29 
neurogenesis. In women, menopause is associated with increased risk of memory disturbances, which 30 
can be attenuated by timely estrogen therapy. In animal models of menopause, 17-estradiol (E2) 31 
replacement improves hippocampus-dependent spatial memory. Here, we explored the effect of E2 32 
replacement on hippocampal gene expression in a rat menopause model. Middle-aged ovariectomized 33 
female rats were treated continuously for 29 days with E2 and then, the hippocampal transcriptome 34 
was investigated with Affymetrix expression arrays. Microarray data were analyzed by Bioconductor 35 
packages and web-based softwares, and verified with quantitative PCR.  At standard fold change (FC) 36 
selection criterion, 156 genes responded to E2. All alterations but four were transcriptional activation. 37 
Robust activation (FC>10) occurred in the case of transthyretin, klotho, claudin 2, prolactin receptor, 38 
ectodin, coagulation factor V, insulin-like growth factor 2, Igfbp2 and sodium/sulfate symporter. 39 
Classification of the 156 genes revealed major groups including signaling (35 genes), metabolism (31 40 
genes), extracellular matrix (17 genes) and transcription (16 genes). We selected 33 genes for further 41 
studies and all changes were confirmed by real-time PCR. The results suggest that E2 promotes 42 
retinoid, growth factor, homeoprotein, neurohormone and neurotransmitter signaling, changes 43 
metabolism, extracellular matrix composition, transcription, and induce protective mechanisms via 44 
genomic effects. We propose that these mechanisms contribute to effects of E2 on neurogenesis, 45 
neural plasticity and memory functions. Our findings provide further support for the rationale to 46 
develop safe estrogen receptor ligands for the maintenance of cognitive performance in 47 
postmenopausal women.  48 
49 
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Introduction 50 
The hippocampus plays a pivotal role in learning and memory (1). Gonadal steroids, including 17-51 
estradiol (E2), are powerful modulators of the hippocampal functions (2-4). Accordingly, E2 shapes 52 
dendritic spine density of principal neurons during the estrous cycle (5), modulates neurogenesis (6,7), 53 
alters neurotransmission (8), provides neuroprotection (9,10) and regulates the innate immune system 54 
(11,12). In women, menopause is associated with increased risk of hippocampal decline and memory 55 
disturbances (13,14). Estrogen replacement therapy (ERT) is effective in some, but not all women to 56 
attenuate menopause-related memory disturbances. The effects of ERT on hippocampus and memory 57 
are complex, and the effects depend on many parameters including estrogen responsiveness of the 58 
individual, the chemical structure of the active estrogen compound, dosage and initiation of treatment, 59 
among others (15). It has been proposed that a critical period exists for beneficial estrogen effects (16-60 
18). In accord with the hypothesis, perimenopausal and early postmenopausal hormone therapies are 61 
often associated with improved cognitive functions later in life (19-22). However, the clinical practice 62 
lacks an effective ERT to treat menopause-related decline of cognitive performance. 63 
E2 improves some aspects of cognitive performance in many rat studies. In young 64 
ovariectomized (OVX) female rats, E2 replacement (29 pg/mL of serum E2) increases working 65 
memory (23). In another study, E2 replacements (25 and 50 pg/mL of serum E2) enhance spatial 66 
memory, and improve adaptation to increasing amounts of working memory information (24). In the 67 
case of high memory demand, high-dose E2-replaced animals even outperform intact cycling females 68 
(24). The middle-aged OVX rat (25) is a widely used rodent model of menopause.  In this model, 69 
immediate E2 replacement (20-25 pg/mL of serum E2) following OVX enhances acquisition during a 70 
working memory task, but treatment several month after OVX was ineffective (26). Orally 71 
administered E2 improves spatial memory, but E2 plus medroxyprogesterone-acetate treatment 72 
impairs performance (27). Additional studies also find that E2 improves hippocampus-dependent 73 
spatial memory (28-31). Current studies from the Daniel laboratory show that transient exposure of E2 74 
after OVX (37 pg/mL of serum E2 levels) provides enduring benefits on the hippocampus and 75 
memory (32,33). Although many animal studies have demonstrated the positive effect of E2 on 76 
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cognitive performance, it should be noted that the effects are moderate and not all studies have found 77 
beneficial effects. 78 
E2 exerts genomic nuclear actions (34) and nongenomic membrane actions (35). We 79 
hypothesize that genomic effects contribute to the impact of E2 on the hippocampus. Estrogen 80 
receptor-alpha (ER), ER and GPR30 are expressed in the rat hippocampus at mRNA and protein 81 
levels (36-38). Genomic effects change with age which is partly due to the altered ratio of the ER 82 
and ER subtypes (39). Relatively little information is currently available on the impact of E2 on 83 
hippocampal gene expression, and a comprehensive list of E2 regulated genes is still missing from the 84 
public domain. Therefore, elucidation of E2 target genes and estrogen driven regulatory mechanisms 85 
await further clarification. In this study, we identified 156 E2-regulated genes in middle-aged OVX 86 
rats and proposed major downstream regulatory mechanisms of E2 action, which underlie its impact 87 
on hippocampal functions of postmenopausal females.  88 
 89 
Materials and Methods 90 
Experimental animals 91 
All studies were carried out with permission from the Animal Welfare Committee of the 92 
Institute of Experimental Medicine (IEM, Permission Number: A5769-01) and in accordance with the 93 
legal requirements of the European Community (Decree 86/609/EEC). Animal experimentation was 94 
conducted in accord with accepted standards. Female Harlan-Wistar female rats (n=16) were 95 
originally purchased from Toxicoop (Budapest, Hungary) and housed on a 12h light/12h dark cycle in 96 
the animal care facility of IEM. At their age of 9 month, they were retired as breeders and were housed 97 
individually for the subsequent months. Although environmental complexity may have an effect on the 98 
hippocampal formation of adult rats (40), any housing effect is excluded by comparing the E2-99 
replaced group to the vehicle-treated one. Studies, which were performed in our animal facility, 100 
provided evidence that separate housing does not change basal corticosterone levels in rats (41). At 101 
their age of 13 months, the rats were deeply anesthetized and OVX bilaterally. Afterward, they were 102 
kept on phytoestrogen-free diet (Harlan Teklad Global Diets, Madison, WI). Ten days later, Alzet 103 
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2004 osmotic minipumps (DURECT, Cupertino, CA) filled either with E2 (0,33mg/ml in propylene-104 
glycol, n=8, E2 group) or vehicle only (n=8, control group) were implanted subcutaneously for 29 105 
days in the scruff of the neck of the animals. We reported previously that these subcutaneous 106 
treatments result 29.5 and 2.4 pg/mL serum E2 levels in E2- and vehicle-treated animals, respectively 107 
(42). Body weight of control animals increased, while of E2-replaced animals decreased in accordance 108 
with the anorexigenic effect of E2. 109 
Microarray using Affymetrix Rat Genome 230 PM Strip Arrays 110 
Hippocampi from 16 animals were prepared and total RNA was isolated and analyzed as 111 
previously (12). RNA quality was measured by capillary electrophoresis using Nano RNA chips and 112 
RNA integrity was determined by the software of 2100 Agilent Bioanalyzer (Santa Clara, CA, USA). 113 
RNA samples displayed high RNA integrity numbers (RIN > 8.2). Eight samples were examined by 114 
oligonucleotide microarray. Microarray experiments, including amplification, target labeling, 115 
hybridization, staining and scanning, were carried out as described earlier (43). In brief, 25 ng of total 116 
RNA Whole Transcriptome Amplification (WTA) library preparation and amplification for 17 cycles 117 
were performed following the distributor's (Sigma-Aldrich) recommendations. 8 µg cDNA was 118 
fragmented by DNAseI and biotinylated by terminal transferase obtained from the GeneChip Mapping 119 
250K Nsp Assay Kit (Affymetrix Inc, Santa Clara, CA, USA). Hybridization, washing, staining and 120 
scanning of Affymetrix Rat Genome 230 PM Strip arrays were performed following the 121 
manufacturer’s recommendations. Scanned images (DAT files) were transformed into intensities (CEL 122 
files) using the AGCC software (Affymetrix). Data analysis, including GCRMA, statistical and data 123 
mining work, were carried out as described earlier (42). Gene Ontology (GO) term enrichment was 124 
analyzed using a public functional annotation tool (DAVID Bioinformatics Resources; 125 
http://david.abcc.ncifcrf.gov) at default setting (44), but classification stringency was set to high. 126 
Annotation clusters were ranked by their score number, termed enrichment score, calculated from the 127 
modified Fisher’s exact p-value of each GO-term. 128 
Real-time PCR Studies 129 
Custom TaqMan microfluidic cards (Applied Biosystems, Foster City, CA, USA) were 130 
designed to study mRNA expression by real-time PCR. Sixteen samples were investigated by PCR. 131 
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One g of total RNA was used for reverse transcription. Reverse transcription and PCR were carried 132 
out as described earlier (12). The ViiA7 RUO 1.2.1 (Applied Biosystems) software and relative 133 
quantification against calibrator samples (Ct) were used for data evaluation. Glyceraldehyde-3-134 
phosphate dehydrogenase (Gapdh) and hypoxanthine guanine phosphoribosyl-transferase (Hprt) were 135 
used as housekeeping genes. Expression of these genes did not vary among treatment groups. A 136 
computed internal control corresponding to the geometric mean of cycle threshold (Ct) values of 137 
Gapdh and Hprt was used for Ct calculation. The use of TaqMan Gene Expression Assays and the 138 
equal amount of templates allowed us to categorize the genes according to mRNA expression levels 139 
by comparing their Ct values. E2-evoked genes were ranked into three arbitrary categories based on 140 
their abundant (Ct<25), moderate (25<Ct<28) or low (Ct>28) level of mRNA expression. PCR data 141 
evaluation and correlation analysis were performed as described previously (12).  142 
 143 
Results 144 
Oligonucleotide microarray revealed robust transcriptional activation in the hippocampus after 145 
E2 replacement 146 
Two hundred and sixty-two transcripts showed the absolute FC higher than 1.5, which we 147 
considered as a criterion of E2 responsiveness. The 256 activated and 6 suppressed transcripts 148 
included 152 and 4 protein coding genes, respectively (Supplemental Table 1). The rest, 106 149 
transcripts without currently known protein products, was not analyzed further. The heat map shows 150 
mRNA level of the top differentially expressed genes in the hippocampus of 4 vehicle- and 4 E2-151 
treated OVX animals (Fig. 1). It shows small variability within treatment groups. As the color code 152 
indicates dark green, light green and orange represent very low, slight and moderate mRNA levels, 153 
respectively. The heat map shows a green to orange/red transition from left to right in color pattern 154 
illustrating the robust transcriptional activation in response to E2, as the leading trend.  155 
Nine genes, including transthyretin (Ttr), klotho (Kl), claudin (Cldn2), prolactin receptor 156 
(Prlr), ectodin/wise (Sostdc1), coagulation factor V (F5), insulin-like growth factor 2 (Igf2), IGF 157 
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binding protein (Igfbp2) and sodium/sulfate symporter (Slc13a4) showed the most robust increase 158 
(FC>10) in mRNA expression. We termed these prime E2 target genes (Table 1).  159 
Twelve genes showed considerable activation of transcription (10>FC>4) and encoded folate 160 
receptor (Folr1),  type I collagen (Col1a2), HT2C receptor (Htr2c), secreted frizzled-related protein 161 
(Sfrp1),  type VIII collagen (Col8a2), membrane frizzled-related protein (Mfrp),  type III collagen 162 
(Col3a1), orthodenticle homeobox (Otx2), angiotensin-converting enzyme (Ace), midkine (Mdk), 163 
ectonucleotide phosphodiesterase family member 2/autotaxin (Enpp2) and  type I collagen (Col1a1). 164 
We named these substantial E2 target genes (Table 1).  165 
Forty genes showed moderate (4>FC>2) activation (Supplemental Table 1) including 166 
p57/Kip2 (Cdkn1c), prostaglandin D2 synthase (Ptgds), subfamily E potassium voltage-gated channel 167 
(Kcne2), matrix metalloproteinase 2 (Mmp2), Msh homeobox 1 (Msx1), glycosylation-dependent cell 168 
adhesion molecule (Glycam1), mannose receptor 1 (Mrc1), p21/CIP1 (Cdkn1a) and extracellular 169 
superoxide dismutase (Sod3). We called these genuine E2 target genes. 170 
Functional annotation identified clusters of E2-regulated genes 171 
The 156 differentially expressed genes were analyzed using a functional gene annotation tool 172 
DAVID (44), which generated a ranked list of clusters by grouping gene annotation terms based on 173 
their similarity. Annotation clusters were ranked according to their enrichment score (ES), a factor 174 
calculated from the adjusted p-values of terms. Top annotation clusters were arbitrarily named and 175 
listed according to their enrichment scores (ES). Top clusters (Supplemental Table 2) with high ES 176 
included response to hormones (4.23), pattern binding (3.95), cell motility (3.72), development (3.37), 177 
retinoid (3.19) and collagen (2.08). Indeed, activation of several growth factors, homeobox proteins, 178 
cell-cycle regulators and metabolic enzymes resembles earlier developmental stages. The 156 E2-179 
regulated genes were enriched at the highest confidence in the response to hormones cluster. This 180 
cluster included TIMP metallopeptidase inhibitor (Timp3), aldehyde dehydrogenase (Aldh1a2), alpha-181 
2-macroglobulin (A2m), aquaporin 1 (Aqp1), Col1a1, Cdkn1a, glutathione peroxidase (Gpx1), Igf1, 182 
Igf2, Igfbp2,  matrix Gla protein (Mgp), matrix metalloproteinase 14 (Mmp14), Mdk, platelet-derived 183 
growth factor receptor alpha (Pdgfra), Ptgds and retinol binding protein 4 (Rbp4). Noteworthy, that 184 
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the “response to hormones” cluster contained only two of the nine prime E2 target genes indicating 185 
partial knowledge on E2-responsive genes. 186 
Classification of E2-induced genes  187 
Classification of the 156 E2-regulated genes based on biological function revealed nine groups 188 
including cell adhesion, cytoskeleton, extracellular matrix, immune, metabolism, miscellaneous, 189 
signaling, transport and transcription (Fig. 2). 190 
Cell adhesion  191 
This group contained twelve genes including Cldn1, Cldn2, cingulin-like 1 (Cgnl1), glycosylation-192 
dependent cell adhesion molecule, gap junction protein beta 2, ADAMTS-like 4, six transmembrane 193 
epithelial antigen, desmoglein, occludin (Ocln), lectin (Lgals3bp), InaD-like 2 (Inadl2) and anthrax 194 
receptor. Five genes (Cldn1, Cldn2, Cgnl1, Inadl2, Ocln) in the group encoded tight junction proteins. 195 
Cytoskeleton  196 
Cytoskeletal genes comprised ezrin (Ezr), tubulin beta (Tubb4b), alpha actin (Acta2), dynein light 197 
chain (Dynlrb2), vimentin (Vim), filamin A (Flna), vinculin (Vcl), tensin-1 (Tns1) and troponin C 198 
(Tnnc2). Their changes in mRNA expression were modest.  199 
Extracellular matrix (ECM) 200 
The ECM group composed of seventeen genes including six collagens (Col1a2, Col8a2, Col3a1, 201 
Col1a1, Col6a2, Col9a3), four small leucine-rich proteoglycans (osteoglycin, decorin, lumican, 202 
biglycan), two laminins (Lama2, Lama3), Mgp, prolargin (Prelp), cartilage associated protein (Crtap), 203 
nidogen (Nid1) and fibulin-2 (Fbln2). Collagens and proteoglycans showed considerable changes in 204 
response to E2. 205 
Immune  206 
This small set of genes contained mannose receptor (Mrc1), chemokine ligand (Cxcl16), lysozyme 207 
(Lyz2), interleukin 1 receptor (Il1r1), IFN-induced transmembrane protein (Ifitm3). These immune 208 
genes were likely of glial sources. 209 
Metabolism  210 
This group consisted thirty-one genes which were involved in retinol binding (Rbp1 and Rbp4, Crabp2 211 
and stimulated by retinoic acid gene Stra6), retinoic acid synthesis (Rdh10, Aldh1a2), lipid messenger 212 
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synthesis (autotoxin Enpp2, prostaglandin D2 synthase, phospholipase Pla2g5), protection against 213 
oxidative stress (extracellular superoxide dismutase, phosphatidylinositol-4-phosphate 5-kinase 214 
(Pip5k1b), Gpx1, glutathione S-transferase Gsta4 and Gstm2) as well as cargo transport (Ttr, A2m, 215 
Tcn2). 216 
Signaling  217 
This large set of genes included thirty-five genes that encode klotho (Kl), prolactin receptor (Prlr), 218 
ectodin/wise (Sostdc1), Igf2, Igfbp2, folate receptor (Folr1), HT2C receptor, secreted frizzled-related 219 
protein (Sfrp), membrane frizzled-related protein (Mfrp), midkine (Mdk), p57/Kip2, annexin 2, 220 
disabled homolog 2, p21/CIP1, Kunitz type 2 inhibitor, follistatin-like 1, Notch ligand and receptor 221 
(Jag1, Notch2), regulatory subunit of protein phosphatase 1, connective tissue growth factor, Igf1, 222 
calmodulin-like 4, Igf binding protein-like 1, a disintegrin and metalloproteinase with thrombospondin 223 
motif 1, transforming growth factor  receptor 3, ADP-ribosylation factor-like 4, wntless homolog, 224 
vav guanine nucleotide exchange factor 3, GTPase activating protein with IQ motif, sumo-specific 225 
peptidase, platelet endothelial aggregation receptor, serine threonine kinase 39, ajuba LIM protein, 226 
platelet-derived growth factor receptor alpha, cocaine-amphetamine regulated transcript. E2 robustly 227 
activated Kl, Prlr, Sostdc1, Igf2 and Igfbp2, and considerably induced Folr1, Htr2c, Sfrp1, Mfrp and 228 
Mdk. 229 
Transcription  230 
This group comprised seven transcription factors (Otx2, TSC22 domain family Tsc22d2, ZIC family 231 
member Zic1 and Zic4, class E basic helix-loop-helix Bhlhe40, Sp1, butyrate response factor Zfp36l1), 232 
seven transcriptional modulators (Msx1, C2H2 Zn finger Plagl1, MyoD family inhibitor domain-233 
containing Mdfic, ETS domain-containing Elk3, ets variant Etv3, homeobox interacting protein 234 
Pbxip1, homeobox protein Zeb2), as well as histone cluster 1 protein (Hist1h4b), and mRNA 235 
stabilization factor ELAV-like protein (Elavl1).  236 
Results of real-time PCR study confirmed microarray data 237 
Thirty-three genes were selected from the top of the microarray gene list for further studies 238 
using real-time PCR. The PCR study showed strong transcriptional activation in the hippocampus after 239 
E2 replacement (Table 2). All of the changes were confirmed and found to be statistically significant 240 
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(p<0.05). The PCR study allowed us to perform correlation analysis and to determine the correlation 241 
coefficient (R) among gene pairs. The R matrix of the prime E2 target genes revealed correlation in 242 
several cases (Supplemental Table 3). Strong correlation (R>0.98) was shown in case of Ttr-Igf2, 243 
Ttr-Igfbp2, Prlr-Sostdc1, Sostdc1-Slc13a4 and Igf2-Igfbp2. Three of the five gene pairs contain Igf2 244 
suggesting that the protein product of activated Igf2 may evoke secondary transcriptional effects. The 245 
other two pairs include Sostdc1 suggesting the potential involvement of this BMP antagonist in 246 
secondary estrogenic effects. PCR experiments also provided information on the level of gene 247 
expression. In the vehicle treated OVX animals, we found considerable level (Ct<25) of mRNA 248 
expression for Ttr, Enpp2, Ptgds, Gpx1. Moderate (25<Ct<28) expression was detected in case of Igf2, 249 
Igfbp2, Htr2c, Sfrp1, Ace, Mdk, Cdkn1c, Msx1, A2m, Sod3, Rdh10. The rest of the genes were 250 
expressed weakly (data not shown). A complete list of gene symbols in alphabetical order and the 251 
corresponding gene names can be found in Supplemental Table 4. 252 
Due to our special interest and their significant role in hippocampal regulation, we studied the 253 
putative estrogenic regulation of additional genes. The PCR study revealed that corticotropin releasing 254 
hormone receptor 2 (Crhr2), serum and glucocorticoid-regulated kinase 1 (Sgk1), Na-K-Cl 255 
cotransporter (Slc12a2), vesicular glutamate transporter 1 (Slc17a7) and vesicular inhibitory amino 256 
acid transporter (Slc32a1) were regulated by E2 (Table 2). 257 
 258 
Discussion 259 
In animal models of menopause, E2 exposure exerts a strong and enduring impact on hippocampal 260 
functions, but the underlying mechanisms remain elusive. In this study, we compared the hippocampal 261 
transcriptomes of middle-aged, OVX E2-replaced and vehicle-treated rats, and identified 156 estrogen 262 
responsive genes. We conclude that in middle-aged, gonadal steroid deficient female rats i) the 263 
hippocampal transcriptome is highly responsive to E2; ii) major E2 target genes include Ttr, Kl, 264 
Cldn2, Prlr, Sostdc1, Igf2, Igfbp2, Folr1, Htr2c, Sfrp1, Otx2, Ace, Mdk and Enpp2; iii) top functional 265 
categories of E2-regulated gene clusters comprise signaling, metabolism, ECM and transcription; iv) 266 
E2 can induce downstream events consisting elevated retinoid, klotho, insulin-like growth factor, Otx2 267 
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homeoprotein and serotonin signaling; v) the above mentioned E2-activated genes and downstream 268 
signaling mechanisms are known to control neurogenesis, the processes of synaptic plasticity and 269 
protective mechanisms, all responsible for the integrity, networking and proper function of the 270 
hippocampal formation. 271 
Transcriptional fingerprint of chronic E2 treatment in the hippocampus 272 
To date, transcriptional effects of chronic E2 treatments have been investigated in the 273 
hippocampus of middle-aged OVX mice. In this model, cyclic estradiol-benzoate treatment modestly 274 
regulates 2089 probes (45). The discrepancy between the subtle mouse and robust rat estrogenic 275 
regulation of gene expression is not fully understood, but may reflect the distinct treatment paradigms 276 
and the different distribution and expression of ER in the two species at midlife (36,46). 277 
We previously found in the frontal cortex that chronic E2 treatment caused moderate transcriptional 278 
changes including activation of dopamine receptors, signaling regulators, neuropeptides (42) and 279 
suppression of immune genes (42,47,48). On the other hand, E2 robustly activates transcription in the 280 
hippocampus. E2 target genes encoded signaling molecules, metabolic enzymes, ECM components 281 
and transcriptional regulators. Comparison of the E2-evoked changes revealed great difference in 282 
estrogen sensitivity of the two transcriptomes. In the two areas, several genes including signaling 283 
molecules (Igf2, Igfbp2, Cartpt), ECM genes (Col1a1, Col1a2, Col3a1, Lum, Ogn) and transcriptional 284 
regulators (Bhlhe40) showed opposite regulation. There was no overlap in the metabolism group. 285 
Immune related changes were similar in the frontal cortex (48) and the hippocampus (12).  286 
E2 influences signaling mechanisms through genomic effects 287 
1. Transthyretin and retinoid signaling  288 
Transthyretin transports retinol binding protein-retinol complex from the liver to target tissues. 289 
It is expressed highly in the liver and the choroid plexus, but it is also present in the hippocampus 290 
(49,50). Transthyretin is implicated in the maintenance of memory capacities as decreased 291 
hippocampal expression of the gene is associated with the development of age-related memory 292 
impairment (51). Transthyretin also sequesters beta-amyloid peptide (52). Therefore, robust increase 293 
in Ttr expression following E2 replacement may lead to enhanced availability of retinoids and 294 
accelerated clearance of neurotoxic peptides in the hippocampus.  The rat and human Ttr genes 295 
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contain a putative ERE sequence in the 5' flanking region between -3406 and -3392. In agreement with 296 
the robust transcriptional activation of Ttr, this distal ERE is functional and shows the characteristics 297 
of an E2-dependent enhancer-like element (53). This example highlights the importance of distal 298 
regulatory elements in E2-dependent transcriptional regulation (54). 299 
Retinoic acid (RA), generated from retinol via a retinaldehyde intermediate, regulates 300 
transcription and intracellular signaling pathways. We demonstrated that E2 activates transcription of 301 
several genes associated with serum retinol transport (Ttr), retinol binding (Rbp1, Rbp4), membrane 302 
retinol receptor (Stra6), intracellular retinol binding (Crabp2), conversion of retinol to retinaldehyde 303 
(Rdh10) and its metabolism to RA (Aldh1a2). Transcriptional activation of these genes may result 304 
elevated RA levels in the hippocampus. RA and its receptors are essential for long-term potentiation 305 
and depression (55), play indispensable role in neurogenesis (56) and take part in the regulation of 306 
homeostatic synaptic plasticity (57). RA also increases de novo synthesis of E2 and testosterone in 307 
hippocampal slice cultures via transcriptional regulation of steroidogenic enzymes (58). These data 308 
suggest that increased expression of transthyretin and key enzymes of retinol metabolism contributes 309 
to the effects of E2 on neuronal plasticity, neurogenesis, and maintains local E2 synthesis in the 310 
hippocampus via retinoid signaling. 311 
Midkine is a RA inducible growth factor, which promotes neurite extension, survival and 312 
migration of neurons (59). It is also expressed in neural stem and progenitor cells (NSPC) and 313 
enhances their growth and survival (60). E2 evoked transcriptional activation of Mdk in the 314 
hippocampus may promote neurite outgrowth (61), receptor clustering and synapse formation (62), 315 
neuronal survival and neurogenesis (63). 316 
2. Klotho signaling  317 
Klotho is a known aging suppressor. It is a transmembrane protein which is liberated from the 318 
plasma membrane by enzymatic cleavage. Its absence leads to premature aging and shortened life span 319 
in mice (64). Conversely, its overexpression extends life span and provides protection against 320 
oxidative stress (65). Klotho is expressed widespread in the rat brain including the hippocampus (66). 321 
In the brain, the expression of klotho decreases with age (67). We found that E2 robustly increases 322 
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klotho expression which may promote anti-aging klotho signaling. Our finding is the first evidence 323 
that klotho is a prime E2 target gene. 324 
3. Insulin-like growth factor signaling 325 
Insulin-like growth factor 2 plays a pivotal role in adult hippocampal functions such as 326 
neurogenesis (68), memory consolidation and enhancement (69). Igf2 exerts its effects via the receptor 327 
tyrosine kinase IGF-1R (70), which is strongly expressed in the hippocampus (71). The receptor is 328 
often colocalized with the two ER subtypes (72). Through IGF-1R, Igf2 activates the ERK/MAPK and 329 
PI3K-Akt signaling pathways resulting in phosphorylation and ligand-independent activation of ER 330 
(73,74). Association between ER- and IGF-1R- mediated signal transduction pathways is supported 331 
further by a recent study demonstrating that subsequent IGF-1R antagonism terminates the memory 332 
enhancing effect of short-term E2 treatment in OVX female rats (75). Based on the close linkage of 333 
estrogen and insulin-like growth factor signaling, we propose that in the hippocampus, robust 334 
activation of Igf2 is one of the most important downstream events in E2 signaling. 335 
Igfbp2 controls Igf half life and receptor availability. Binding of Igfbp2 modulates affinity for 336 
glycosaminoglycans and activation of Igf receptors. It is noteworthy that E2 activates the transcription 337 
of seventeen ECM genes including four proteoglycans. Both Igf2 and Igfbp2 were found to respond to 338 
E2 in the hippocampus of young OVX rats (76).  339 
Insulin-like growth factor 1 is produced mainly in the liver but also synthesized by neurons 340 
and astrocytes in the hippocampus, where it regulates neurotransmission (77,78) and neurogenesis 341 
(79). Accumulating evidence indicates a putative role of Igf1 in the improvement of anxiety and 342 
memory deficits (80,81).  343 
Besides midkine, klotho, Igf2 and Igf1, E2 enhances mRNA expression of additional growth 344 
factors. Connective tissue growth factor (Ctgf) is a secreted, ECM-associated protein that plays a role 345 
in adhesion, migration, mitogenesis, differentiation and survival. Ctgf has been detected in layer VII 346 
neurons of the cerebral cortex and weakly in the hippocampus (82). Platelet-derived growth factor 347 
receptor  is an oligodendrocyte progenitor marker (83). 348 
349 
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4. Neuropeptide signaling 350 
Prolactin receptors mediate trophic actions of prolactin such as neurogenesis (84,85), 351 
myelinization (86) and neuroprotection (87). Estrogens are required for optimal prolactin response as 352 
OVX mice show reduced levels of pSTAT5 in the CNS (88). Prolactin receptor is robustly upregulated 353 
after E2 replacement in the hippocampus resulting in elevated sensitivity for the modulatory and 354 
trophic actions of prolactin.  355 
E2 activates the transcription of Ace. Angiotensin-converting enzyme converts angiotensin I 356 
to angiotensin II (AII), and degrades vasoactive peptides. The hippocampus contains one of the 357 
highest levels of AII (89) indicating considerable level of basal Ace expression. In concert with this, 358 
our PCR study revealed moderate mRNA expression of Ace in the hippocampus. AII immuno-359 
reactivity was detected in the CA1, CA3 and dentate gyrus (90), while its receptors were detected in 360 
the dentate gyrus (91). The marked increase of ACE expression may lead to elevation of AII level in 361 
the hippocampus which may affect learning and memory processes (92,93).  362 
Corticotropin-releasing hormone receptor 2 is one of the two CRH receptors. In response to 363 
stress, rapid activation of the hypothalamic-pituitary-adrenal (HPA) axis is governed by hypothalamic 364 
CRH. The two CRH receptors inversely regulate stress sensitivity: CRHR1 facilitates while CRHR2 365 
attenuates activation of the HPA axis (94). Sex hormones regulate the expression of CRH and CRH 366 
receptors (95). We found that E2 robustly increased the expression of Crhr2 in the hippocampus. In 367 
concert with our finding, the Crhr2 promoter contains ERE half sites and an androgen response 368 
element (96).  369 
Cocaine- and amphetamine-regulated transcript (CART) is modestly expressed in the 370 
hippocampus, where it modulates voltage-gated Ca++ signaling in neurons (97). We showed that E2 371 
slightly downregulates Cart in the hippocampus.  372 
5. Ectodin and Wnt signaling 373 
Ectodin/wise/USAG-1 is a Wnt/bone morphogenetic protein antagonist. By binding to BMPs, 374 
it regulates their signaling during cellular proliferation and differentiation (98,99). Secreted frizzled-375 
related protein 1 is also a negative soluble regulator of Wnt signaling. It can bind Wnt proteins and 376 
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frizzled (Fz) receptors preventing Wnt binding to Fz (100). Mfrp, membrane-type frizzled-related 377 
protein is also a Wnt regulator.  378 
Wntless/Gpr177 is a 7TM Wnt cargo receptor and essential component of the Wnt secretion 379 
machinery (101). Wntless shuttles Wnt to postsynaptic terminals (102). Wnt ligands and other Wnt 380 
signaling molecules modulate synaptic transmission (103). It is proposed that Wnt signaling plays a 381 
major role in the modulation of synaptic plasticity at mature synapses.  382 
6. Notch signaling 383 
Notch2 and Jagged1 interaction plays a role in cell-cell communication (104). We found that 384 
E2 enhanced mRNA expression of both Notch2 and Jagged1 which may result elevated Notch-385 
mediated communication in the middle-aged female hippocampus after E2 replacement. Notch 386 
signaling plays a pivotal role in synaptic plasticity, learning and memory, and the maintenance of 387 
NCPCs (105,106). 388 
7. OTX2 homeoprotein signaling 389 
 OTX2, member of the homeoprotein family of transcription factors, can pass between cells by 390 
nonconventional mechanisms (107). The role of OTX2 in late postnatal periods and in adulthood is 391 
poorly understood. Maturation of fast-spiking interneurons is associated with periods when the visual 392 
cortex responds to environmental stimuli by physiological and morphological alterations (108). This 393 
critical period depends on the accumulation of OTX2 in parvalbumin-containing interneurons (109). 394 
We found considerable transcriptional activation of Otx2 and propose that E2 may influence 395 
hippocampal plasticity through OTX2 signaling.  396 
E2 alters composition of the extracellular matrix  397 
E2 increased mRNA expression of components of the ECM (type I, III collagens) and matrix 398 
metalloproteinase 2 indicating a reorganization of the ECM in the hippocampus. The ECM provides a 399 
structural framework, acts as a storage deposit for growth factors and cytokines, regulates proliferation 400 
and differentiation of NSPCs, and allows migration of differentiated neurons to various areas of the 401 
hippocampal formation. Therefore, the structure and composition of the ECM influence neuronal 402 
plasticity and neurogenesis (110). NSPCs in the subgranular zone (SGZ) of the dentate gyrus 403 
proliferate throughout life (111,112). Signaling molecules such as hormones and growth factors 404 
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promote proliferation and differentiation of these cells (113), and their incorporation into the 405 
hippocampal network. Dividing cells and young, migrating neurons in the dentate gyrus express both 406 
ER subtypes (114). E2 modulates proliferation and survival of newly born cells in the dentate gyrus 407 
(115). Besides estrogens, these cells respond to other factors via ER, as ER antagonist ICI 182,780 408 
blocks the effect of IGF1 on cell proliferation (116). As transthyretin and Igf2 are critical regulators of 409 
NSPCs (68), our results suggest that E2 controls neurogenesis, at least in part, via genomic effects 410 
including robust upregulation of Ttr and Igf2. 411 
E2 modulates neurotransmission via gene expression 412 
1. HT2C receptor and serotonergic neurotransmission 413 
HT2C receptor is abundantly expressed in the CA1, CA2, CA3 pyramidal cell layer, and is also 414 
expressed in the dentate gyrus (117). Serotonin regulates neuronal network excitability and modulates 415 
adult neurogenesis in the hippocampus (118). Granule cells and interneurons in the dentate gyrus 416 
receive serotonergic input from the brain stem (119). HT2C is one of the receptor subtypes which 417 
mediates the effect of serotonin on neurogenesis (119). Inhibition of the key enzyme of serotonin 418 
synthesis, or lesion of serotonergic neurons decrease neurogenesis (120). Chronic use of fluoxetine 419 
increases neurogenesis in adult rats (121,122). Strong evidence indicates the involvement of serotonin 420 
in the neurogenic effects of E2 in the adult dentate gyrus (123). Serotonin dependence of physical 421 
activity-induced adult hippocampal neurogenesis highlights further the importance of this mechanism 422 
(124).  423 
The hippocampal network generates characteristic, state-dependent activity patterns including 424 
theta oscillations. It largely depends on cholinergic and GABAergic inputs from the medial septum 425 
(125). Theta oscillations are suppressed by serotonin via activation of HT2C receptors (126). In 426 
conclusion, considerable increase of HT2C receptor expression may influence network excitability, 427 
neurogenesis and theta oscillations. 428 
2. GABAergic and glutamatergic neurotransmission  429 
E2 regulated mRNA expression of two GABA (Slc6a13, Slc32a1) and a glutamate transporter 430 
(Slc17a7) gene. Slc17a7 encodes vesicular glutamate transporter 1 (Vglut1), which is expressed in all 431 
principal cells of the hippocampus (127). Slc32a1 encodes vesicular GABA transporter, which is 432 
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produced in GABAergic interneurons (128). The expression of these two transporters was slightly 433 
decreased resulting in altered presynaptic activity and synaptic function of both excitatory and 434 
inhibitory neurons (129,130). Slc6a13 encodes GAT2, which is expressed in the cerebral cortex by 435 
neuronal, glial, ependymal and epithelial cells (131). As deletion of this gene neither affects growth, 436 
fertility and life span (132), the functional consequence of the modest upregulation of Slc6a13 requires 437 
clarification.  438 
3. KCNE2 439 
The auxiliary  subunit for pore-forming potassium channel  subunits, KCNE2, regulates potassium 440 
channel voltage-dependence, gating, conductance,  subunit composition and pharmacology (133). 441 
KCNE2 also controls the function of neuronal hyperpolarization-activated, cyclic nucleotide-gated 442 
(HCN) channels. Loss of Kcne2 leads to decreased HCN channel function and increased neuronal 443 
excitability (134). E2 moderately increases mRNA expression of Kcne2 which is in accordance with 444 
the presence of ERE in the Kcne2 promoter (135). As HCN generates the pacemaker current Ih, 445 
upregulation of Kcne2 may result alterations in excitability, synaptic integration and rhythmic 446 
oscillatory activity (136). 447 
E2 tunes innate immune mechanisms 448 
E2 tunes the innate immune system and supports anti-inflammatory mechanisms in the 449 
hippocampus of middle-aged OVX rats (12). In this study, we identified additional immune related 450 
changes including upregulation of Mrc1, Cxcl16, Colec12, Lyz2, Il1r1 and Ifitm3, which support 451 
further the immunomodulatory role of E2 in the limbic system.  452 
E2 may promote antioxidant mechanisms 453 
Reactive oxygen species (ROS), such as superoxide and hydrogen peroxide are generated by 454 
all cells during normal oxidative respiration. In the absence of control mechanisms, ROS cause 455 
oxidative damage to proteins, lipids and DNA (137). It is known that E2 exerts antioxidant activity 456 
(138,139). We demonstrated modest increase in the expression of extracellular superoxide dismutase, 457 
glutathione S-transferases and glutathione peroxidase. Via transcriptional activation of Sod3, Gstm2, 458 
Gsta4 and Gpx1, E2 can modulate cellular respiration, scavenging of superoxide, catabolism of 459 
hydrogen peroxide and metabolic detoxication of xenobiotics.  460 
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 In summary, we provide evidence that the hippocampal transcriptome is highly responsive to 461 
E2 replacement in middle-aged rats shortly after ovariectomy. E2 robustly activates transcription of 462 
152 genes involved in key metabolic and signaling pathways, ECM structure, neurotransmission, 463 
immune and antioxidant mechanisms. Main E2 target genes include transthyretin, klotho, insulin-like 464 
growth factor 2, orthodenticle homeobox 2. The resulting expression profile suggests that E2 465 
replacement evokes downstream events such as activation of retinoid, klotho, insulin-like growth 466 
factor, Otx2 homeoprotein, serotonin signaling mechanisms, which promote plasticity, neurogenesis 467 
and neuroprotection (Fig. 3). We propose that activation of the above mentioned mechanisms 468 
contributes to the improvement of hippocampus-dependent memory performance after chronic 469 
administration of E2 in middle-aged OVX rats (26,27,30-32).  The findings provide further support for 470 
the development of safe ER ligands to prevent memory disturbances and cognitive aging in 471 
postmenopausal women.  472 
 473 
Acknowledgements 474 
We thank the excellent technical assistance from Hajni Bekó and Barna László. This work was 475 
supported by grants from the Hungarian Scientific Research Fund (OTKA K100722), the National 476 
Development Agency of Hungary (NFU-BONUS-HU08/2-2011-0006) and the European 477 
Community’s Seventh Framework Programme (FP7/2007-2013, No.245009). 478 
 479 
480 
 19 
References 481 
1. Buzsaki G, Moser EI. Memory, navigation and theta rhythm in the hippocampal-482 
entorhinal system. Nature neuroscience 2013; 16:130-138 483 
2. Pfaff DW. Autoradiographic localization of radioactivity in rat brain after injection of 484 
tritiated sex hormones. Science 1968; 161:1355-1356 485 
3. Loy R, Milner TA. Sexual dimorphism in extent of axonal sprouting in rat 486 
hippocampus. Science 1980; 208:1282-1284 487 
4. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic 488 
spine density in hippocampal pyramidal cells in adulthood. The Journal of 489 
neuroscience : the official journal of the Society for Neuroscience 1990; 10:1286-1291 490 
5. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in 491 
dendritic spine density on adult hippocampal pyramidal neurons. The Journal of 492 
neuroscience : the official journal of the Society for Neuroscience 1990; 10:4035-4039 493 
6. Tanapat P, Hastings NB, Reeves AJ, Gould E. Estrogen stimulates a transient increase 494 
in the number of new neurons in the dentate gyrus of the adult female rat. The Journal 495 
of neuroscience : the official journal of the Society for Neuroscience 1999; 19:5792-496 
5801 497 
7. Mazzucco CA, Lieblich SE, Bingham BI, Williamson MA, Viau V, Galea LA. Both 498 
estrogen receptor alpha and estrogen receptor beta agonists enhance cell proliferation 499 
in the dentate gyrus of adult female rats. Neuroscience 2006; 141:1793-1800 500 
8. Murphy DD, Cole NB, Greenberger V, Segal M. Estradiol increases dendritic spine 501 
density by reducing GABA neurotransmission in hippocampal neurons. The Journal of 502 
neuroscience : the official journal of the Society for Neuroscience 1998; 18:2550-2559 503 
9. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM. Estradiol rescues neurons from 504 
global ischemia-induced cell death: multiple cellular pathways of neuroprotection. 505 
Steroids 2009; 74:555-561 506 
10. Yang LC, Zhang QG, Zhou CF, Yang F, Zhang YD, Wang RM, Brann DW. 507 
Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the 508 
rat hippocampus. PloS one 2010; 5:e9851 509 
11. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont 510 
S, Ciana P, Chambon P, Maggi A. Estrogen receptor-alpha mediates the brain 511 
antiinflammatory activity of estradiol. Proceedings of the National Academy of 512 
Sciences of the United States of America 2003; 100:9614-9619 513 
12. Sarvari M, Kallo I, Hrabovszky E, Solymosi N, Liposits Z. Ovariectomy and 514 
subsequent treatment with estrogen receptor agonists tune the innate immune system 515 
of the hippocampus in middle-aged female rats. PloS one 2014; 9:e88540 516 
13. Weber MT, Rubin LH, Maki PM. Cognition in perimenopause: the effect of transition 517 
stage. Menopause 2013; 20:511-517 518 
14. Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: 519 
findings from a longitudinal community cohort. The Journal of clinical endocrinology 520 
and metabolism 2013; 98:3829-3838 521 
15. Luine VN. Estradiol and cognitive function: past, present and future. Hormones and 522 
behavior 2014; 66:602-618 523 
16. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a 524 
critical time. Jama 2002; 288:2170-2172 525 
17. Sherwin BB. Estrogen and cognitive functioning in women. Endocrine reviews 2003; 526 
24:133-151 527 
 20 
18. Acosta JI, Hiroi R, Camp BW, Talboom JS, Bimonte-Nelson HA. An update on the 528 
cognitive impact of clinically-used hormone therapies in the female rat: models, 529 
mazes, and mechanisms. Brain research 2013; 1514:18-39 530 
19. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Early postmenopausal 531 
hormone therapy may prevent cognitive impairment later in life. Menopause 2005; 532 
12:12-17 533 
20. Maki PM, Dennerstein L, Clark M, Guthrie J, LaMontagne P, Fornelli D, Little D, 534 
Henderson VW, Resnick SM. Perimenopausal use of hormone therapy is associated 535 
with enhanced memory and hippocampal function later in life. Brain research 2011; 536 
1379:232-243 537 
21. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and 538 
dementia: the critical window theory revisited. Annals of neurology 2011; 69:163-169 539 
22. Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, 540 
Karlamangla AS. Effects of the menopause transition and hormone use on cognitive 541 
performance in midlife women. Neurology 2009; 72:1850-1857 542 
23. Gibbs RB, Johnson DA. Sex-specific effects of gonadectomy and hormone treatment 543 
on acquisition of a 12-arm radial maze task by Sprague Dawley rats. Endocrinology 544 
2008; 149:3176-3183 545 
24. Bimonte HA, Denenberg VH. Estradiol facilitates performance as working memory 546 
load increases. Psychoneuroendocrinology 1999; 24:161-173 547 
25. Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. 548 
Endocrinology 2001; 142:43-48 549 
26. Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in 550 
middle-aged rats when initiated immediately after ovariectomy but not after a long-551 
term period of ovarian hormone deprivation. Endocrinology 2006; 147:607-614 552 
27. Lowry NC, Pardon LP, Yates MA, Juraska JM. Effects of long-term treatment with 17 553 
beta-estradiol and medroxyprogesterone acetate on water maze performance in middle 554 
aged female rats. Hormones and behavior 2010; 58:200-207 555 
28. Foster TC, Sharrow KM, Kumar A, Masse J. Interaction of age and chronic estradiol 556 
replacement on memory and markers of brain aging. Neurobiology of aging 2003; 557 
24:839-852 558 
29. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm AC. Progesterone reverses 559 
the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in 560 
middle-aged ovariectomized female rats. The European journal of neuroscience 2006; 561 
24:229-242 562 
30. Talboom JS, Williams BJ, Baxley ER, West SG, Bimonte-Nelson HA. Higher levels 563 
of estradiol replacement correlate with better spatial memory in surgically menopausal 564 
young and middle-aged rats. Neurobiology of learning and memory 2008; 90:155-163 565 
31. Kiss A, Delattre AM, Pereira SI, Carolino RG, Szawka RE, Anselmo-Franci JA, 566 
Zanata SM, Ferraz AC. 17beta-estradiol replacement in young, adult and middle-aged 567 
female ovariectomized rats promotes improvement of spatial reference memory and an 568 
antidepressant effect and alters monoamines and BDNF levels in memory- and 569 
depression-related brain areas. Behavioural brain research 2012; 227:100-108 570 
32. Rodgers SP, Bohacek J, Daniel JM. Transient estradiol exposure during middle age in 571 
ovariectomized rats exerts lasting effects on cognitive function and the hippocampus. 572 
Endocrinology 2010; 151:1194-1203 573 
33. Witty CF, Gardella LP, Perez MC, Daniel JM. Short-term estradiol administration in 574 
aging ovariectomized rats provides lasting benefits for memory and the hippocampus: 575 
a role for insulin-like growth factor-I. Endocrinology 2013; 154:842-852 576 
 21 
34. Yamamoto K, Alberts B. The interaction of estradiol-receptor protein with the 577 
genome: an argument for the existence of undetected specific sites. Cell 1975; 4:301-578 
310 579 
35. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces calcium currents in rat 580 
neostriatal neurons via a membrane receptor. The Journal of neuroscience : the official 581 
journal of the Society for Neuroscience 1996; 16:595-604 582 
36. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen 583 
receptor-alpha and -beta mRNA in the rat central nervous system. The Journal of 584 
comparative neurology 1997; 388:507-525 585 
37. Shughrue PJ, Merchenthaler I. Evidence for novel estrogen binding sites in the rat 586 
hippocampus. Neuroscience 2000; 99:605-612 587 
38. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI, Prossnitz ER, Dun 588 
NJ. Distribution and characterization of estrogen receptor G protein-coupled receptor 589 
30 in the rat central nervous system. The Journal of endocrinology 2007; 193:311-321 590 
39. Foster TC. Role of estrogen receptor alpha and beta expression and signaling on 591 
cognitive function during aging. Hippocampus 2012; 22:656-669 592 
40. Susser ER, Wallace RB. The effects of environmental complexity on the hippocampal 593 
formation of the adult rat. Acta neurobiologiae experimentalis 1982; 42:203-207 594 
41. Toth M, Mikics E, Tulogdi A, Aliczki M, Haller J. Post-weaning social isolation 595 
induces abnormal forms of aggression in conjunction with increased glucocorticoid 596 
and autonomic stress responses. Hormones and behavior 2011; 60:28-36 597 
42. Sarvari M, Kallo I, Hrabovszky E, Solymosi N, Toth K, Liko I, Molnar B, Tihanyi K, 598 
Liposits Z. Estradiol replacement alters expression of genes related to 599 
neurotransmission and immune surveillance in the frontal cortex of middle-aged, 600 
ovariectomized rats. Endocrinology 2010; 151:3847-3862 601 
43. Gonzalez-Roca E, Garcia-Albeniz X, Rodriguez-Mulero S, Gomis RR, Kornacker K, 602 
Auer H. Accurate expression profiling of very small cell populations. PloS one 2010; 603 
5:e14418 604 
44. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large 605 
gene lists using DAVID bioinformatics resources. Nature protocols 2009; 4:44-57 606 
45. Han X, Aenlle KK, Bean LA, Rani A, Semple-Rowland SL, Kumar A, Foster TC. 607 
Role of estrogen receptor alpha and beta in preserving hippocampal function during 608 
aging. The Journal of neuroscience : the official journal of the Society for 609 
Neuroscience 2013; 33:2671-2683 610 
46. Shughrue PJ, Lane MV, Merchenthaler I. Biologically active estrogen receptor-beta: 611 
evidence from in vivo autoradiographic studies with estrogen receptor alpha-knockout 612 
mice. Endocrinology 1999; 140:2613-2620 613 
47. Sarvari M, Hrabovszky E, Kallo I, Solymosi N, Toth K, Liko I, Szeles J, Maho S, 614 
Molnar B, Liposits Z. Estrogens regulate neuroinflammatory genes via estrogen 615 
receptors alpha and beta in the frontal cortex of middle-aged female rats. Journal of 616 
neuroinflammation 2011; 8:82 617 
48. Sarvari M, Hrabovszky E, Kallo I, Solymosi N, Liko I, Berchtold N, Cotman C, 618 
Liposits Z. Menopause leads to elevated expression of macrophage-associated genes 619 
in the aging frontal cortex: rat and human studies identify strikingly similar changes. 620 
Journal of neuroinflammation 2012; 9:264 621 
49. Dickson PW, Aldred AR, Marley PD, Bannister D, Schreiber G. Rat choroid plexus 622 
specializes in the synthesis and the secretion of transthyretin (prealbumin). Regulation 623 
of transthyretin synthesis in choroid plexus is independent from that in liver. The 624 
Journal of biological chemistry 1986; 261:3475-3478 625 
 22 
50. Hovatta I, Zapala MA, Broide RS, Schadt EE, Libiger O, Schork NJ, Lockhart DJ, 626 
Barlow C. DNA variation and brain region-specific expression profiles exhibit 627 
different relationships between inbred mouse strains: implications for eQTL mapping 628 
studies. Genome biology 2007; 8:R25 629 
51. Brouillette J, Quirion R. Transthyretin: a key gene involved in the maintenance of 630 
memory capacities during aging. Neurobiology of aging 2008; 29:1721-1732 631 
52. Tsuzuki K, Fukatsu R, Yamaguchi H, Tateno M, Imai K, Fujii N, Yamauchi T. 632 
Transthyretin binds amyloid beta peptides, Abeta1-42 and Abeta1-40 to form complex 633 
in the autopsied human kidney - possible role of transthyretin for abeta sequestration. 634 
Neuroscience letters 2000; 281:171-174 635 
53. Martinho A, Santos CR, Goncalves I. A distal estrogen responsive element upstream 636 
the cap site of human transthyretin gene is an enhancer-like element upon ERalpha 637 
and/or ERbeta transactivation. Gene 2013; 527:469-476 638 
54. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol 639 
Endocrinol 2006; 20:1707-1714 640 
55. Chiang MY, Misner D, Kempermann G, Schikorski T, Giguere V, Sucov HM, Gage 641 
FH, Stevens CF, Evans RM. An essential role for retinoid receptors RARbeta and 642 
RXRgamma in long-term potentiation and depression. Neuron 1998; 21:1353-1361 643 
56. Jacobs S, Lie DC, DeCicco KL, Shi Y, DeLuca LM, Gage FH, Evans RM. Retinoic 644 
acid is required early during adult neurogenesis in the dentate gyrus. Proceedings of 645 
the National Academy of Sciences of the United States of America 2006; 103:3902-646 
3907 647 
57. Aoto J, Nam CI, Poon MM, Ting P, Chen L. Synaptic signaling by all-trans retinoic 648 
acid in homeostatic synaptic plasticity. Neuron 2008; 60:308-320 649 
58. Munetsuna E, Hojo Y, Hattori M, Ishii H, Kawato S, Ishida A, Kominami SA, 650 
Yamazaki T. Retinoic acid stimulates 17beta-estradiol and testosterone synthesis in rat 651 
hippocampal slice cultures. Endocrinology 2009; 150:4260-4269 652 
59. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T. Midkine, a 653 
retinoic acid-inducible growth/differentiation factor: immunochemical evidence for 654 
the function and distribution. Developmental biology 1993; 159:392-402 655 
60. Zou P, Muramatsu H, Miyata T, Muramatsu T. Midkine, a heparin-binding growth 656 
factor, is expressed in neural precursor cells and promotes their growth. Journal of 657 
neurochemistry 2006; 99:1470-1479 658 
61. Kaneda N, Talukder AH, Nishiyama H, Koizumi S, Muramatsu T. Midkine, a heparin-659 
binding growth/differentiation factor, exhibits nerve cell adhesion and guidance 660 
activity for neurite outgrowth in vitro. Journal of biochemistry 1996; 119:1150-1156 661 
62. Zhou H, Muramatsu T, Halfter W, Tsim KW, Peng HB. A role of midkine in the 662 
development of the neuromuscular junction. Molecular and cellular neurosciences 663 
1997; 10:56-70 664 
63. Reiff T, Huber L, Kramer M, Delattre O, Janoueix-Lerosey I, Rohrer H. Midkine and 665 
Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. 666 
Development 2011; 138:4699-4708 667 
64. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, 668 
Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, 669 
Nagai R, Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome 670 
resembling ageing. Nature 1997; 390:45-51 671 
65. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, 672 
Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn 673 
CR, Rosenblatt KP, Kuro-o M. Suppression of aging in mice by the hormone Klotho. 674 
Science 2005; 309:1829-1833 675 
 23 
66. Clinton SM, Glover ME, Maltare A, Laszczyk AM, Mehi SJ, Simmons RK, King GD. 676 
Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal 677 
development into adulthood. Brain research 2013; 1527:1-14 678 
67. Duce JA, Podvin S, Hollander W, Kipling D, Rosene DL, Abraham CR. Gene profile 679 
analysis implicates Klotho as an important contributor to aging changes in brain white 680 
matter of the rhesus monkey. Glia 2008; 56:106-117 681 
68. Bracko O, Singer T, Aigner S, Knobloch M, Winner B, Ray J, Clemenson GD, Jr., 682 
Suh H, Couillard-Despres S, Aigner L, Gage FH, Jessberger S. Gene expression 683 
profiling of neural stem cells and their neuronal progeny reveals IGF2 as a regulator of 684 
adult hippocampal neurogenesis. The Journal of neuroscience : the official journal of 685 
the Society for Neuroscience 2012; 32:3376-3387 686 
69. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku 687 
D, Blitzer RD, Alberini CM. A critical role for IGF-II in memory consolidation and 688 
enhancement. Nature 2011; 469:491-497 689 
70. Wada J, Liu ZZ, Alvares K, Kumar A, Wallner E, Makino H, Kanwar YS. Cloning of 690 
cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role 691 
of the receptor in metanephric development. Proceedings of the National Academy of 692 
Sciences of the United States of America 1993; 90:10360-10364 693 
71. Aguado F, Rodrigo J, Cacicedo L, Mellstrom B. Distribution of insulin-like growth 694 
factor-I receptor mRNA in rat brain. Regulation in the hypothalamo-neurohypophysial 695 
system. Journal of molecular endocrinology 1993; 11:231-239 696 
72. Cardona-Gomez GP, DonCarlos L, Garcia-Segura LM. Insulin-like growth factor I 697 
receptors and estrogen receptors colocalize in female rat brain. Neuroscience 2000; 698 
99:751-760 699 
73. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, 700 
Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the 701 
estrogen receptor through phosphorylation by mitogen-activated protein kinase. 702 
Science 1995; 270:1491-1494 703 
74. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, 704 
McLemore MS, Olivo SE, Stoica A. A role for Akt in mediating the estrogenic 705 
functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 706 
2000; 141:4503-4511 707 
75. Nelson BS, Springer RC, Daniel JM. Antagonism of brain insulin-like growth factor-1 708 
receptors blocks estradiol effects on memory and levels of hippocampal synaptic 709 
proteins in ovariectomized rats. Psychopharmacology 2014; 231:899-907 710 
76. Takeo C, Ikeda K, Horie-Inoue K, Inoue S. Identification of Igf2, Igfbp2 and Enpp2 as 711 
estrogen-responsive genes in rat hippocampus. Endocrine journal 2009; 56:113-120 712 
77. Kar S, Seto D, Dore S, Hanisch U, Quirion R. Insulin-like growth factors-I and -II 713 
differentially regulate endogenous acetylcholine release from the rat hippocampal 714 
formation. Proceedings of the National Academy of Sciences of the United States of 715 
America 1997; 94:14054-14059 716 
78. Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolos M, LeRoith D, Nunez A, 717 
Torres-Aleman I. Central actions of liver-derived insulin-like growth factor I 718 
underlying its pro-cognitive effects. Molecular psychiatry 2007; 12:1118-1128 719 
79. Lichtenwalner RJ, Forbes ME, Bennett SA, Lynch CD, Sonntag WE, Riddle DR. 720 
Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-721 
related decline in hippocampal neurogenesis. Neuroscience 2001; 107:603-613 722 
80. Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson 723 
S. Increasing the levels of insulin-like growth factor-I by an IGF binding protein 724 
inhibitor produces anxiolytic and antidepressant-like effects. 725 
 24 
Neuropsychopharmacology : official publication of the American College of 726 
Neuropsychopharmacology 2007; 32:2360-2368 727 
81. Lupien SB, Bluhm EJ, Ishii DN. Systemic insulin-like growth factor-I administration 728 
prevents cognitive impairment in diabetic rats, and brain IGF regulates 729 
learning/memory in normal adult rats. Journal of neuroscience research 2003; 74:512-730 
523 731 
82. Heuer H, Christ S, Friedrichsen S, Brauer D, Winckler M, Bauer K, Raivich G. 732 
Connective tissue growth factor: a novel marker of layer VII neurons in the rat 733 
cerebral cortex. Neuroscience 2003; 119:43-52 734 
83. Kondo T, Raff M. Oligodendrocyte precursor cells reprogrammed to become 735 
multipotential CNS stem cells. Science 2000; 289:1754-1757 736 
84. Shingo T, Gregg C, Enwere E, Fujikawa H, Hassam R, Geary C, Cross JC, Weiss S. 737 
Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by 738 
prolactin. Science 2003; 299:117-120 739 
85. Mak GK, Weiss S. Paternal recognition of adult offspring mediated by newly 740 
generated CNS neurons. Nature neuroscience 2010; 13:753-758 741 
86. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S. White matter 742 
plasticity and enhanced remyelination in the maternal CNS. The Journal of 743 
neuroscience : the official journal of the Society for Neuroscience 2007; 27:1812-1823 744 
87. Tejadilla D, Cerbon M, Morales T. Prolactin reduces the damaging effects of 745 
excitotoxicity in the dorsal hippocampus of the female rat independently of ovarian 746 
hormones. Neuroscience 2010; 169:1178-1185 747 
88. Furigo IC, Kim KW, Nagaishi VS, Ramos-Lobo AM, de Alencar A, Pedroso JA, 748 
Metzger M, Donato J, Jr. Prolactin-sensitive neurons express estrogen receptor-alpha 749 
and depend on sex hormones for normal responsiveness to prolactin. Brain research 750 
2014; 1566:47-59 751 
89. Sirett NE, Bray JJ, Hubbard JI. Localization of immunoreactive angiotensin II in the 752 
hippocampus and striatum of rat brain. Brain research 1981; 217:405-411 753 
90. Haas HL, Felix D, Celio MR, Inagami T. Angiotensin II in the hippocampus. A 754 
histochemical and electrophysiological study. Experientia 1980; 36:1394-1395 755 
91. Millan MA, Kiss A, Aguilera G. Developmental changes in brain angiotensin II 756 
receptors in the rat. Peptides 1991; 12:723-737 757 
92. Melo JC, Graeff FG. Effect of intracerebroventricular bradykinin and related peptides 758 
on rabbit operant behavior. The Journal of pharmacology and experimental 759 
therapeutics 1975; 193:1-10 760 
93. Morgan JM, Routtenberg A. Angiotensin injected into the neostriatum after learning 761 
disrupts retention performance. Science 1977; 196:87-89 762 
94. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other 763 
behaviors. Annual review of pharmacology and toxicology 2004; 44:525-557 764 
95. Ni X, Nicholson RC. Steroid hormone mediated regulation of corticotropin-releasing 765 
hormone gene expression. Frontiers in bioscience : a journal and virtual library 2006; 766 
11:2909-2917 767 
96. Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW. Regulation of 768 
corticotropin-releasing hormone type 2 receptors by multiple promoters and 769 
alternative splicing: identification of multiple splice variants. Mol Endocrinol 2003; 770 
17:395-410 771 
97. Yermolaieva O, Chen J, Couceyro PR, Hoshi T. Cocaine- and amphetamine-regulated 772 
transcript peptide modulation of voltage-gated Ca2+ signaling in hippocampal 773 
neurons. The Journal of neuroscience : the official journal of the Society for 774 
Neuroscience 2001; 21:7474-7480 775 
 25 
98. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, Takahashi S, Akiyama T, 776 
Miyazono K, Yanagisawa M, Sakurai T. USAG-1: a bone morphogenetic protein 777 
antagonist abundantly expressed in the kidney. Biochemical and biophysical research 778 
communications 2004; 316:490-500 779 
99. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R. 780 
Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 781 
2003; 130:4295-4305 782 
100. Rodriguez J, Esteve P, Weinl C, Ruiz JM, Fermin Y, Trousse F, Dwivedy A, Holt C, 783 
Bovolenta P. SFRP1 regulates the growth of retinal ganglion cell axons through the 784 
Fz2 receptor. Nature neuroscience 2005; 8:1301-1309 785 
101. Banziger C, Soldini D, Schutt C, Zipperlen P, Hausmann G, Basler K. Wntless, a 786 
conserved membrane protein dedicated to the secretion of Wnt proteins from signaling 787 
cells. Cell 2006; 125:509-522 788 
102. Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, Gherbesi N, Budnik V. 789 
Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell 2009; 790 
139:393-404 791 
103. Park M, Shen K. WNTs in synapse formation and neuronal circuitry. The EMBO 792 
journal 2012; 31:2697-2704 793 
104. Artavanis-Tsakonas S, Matsuno K, Fortini ME. Notch signaling. Science 1995; 794 
268:225-232 795 
105. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP, Furukawa 796 
K. Involvement of Notch signaling in hippocampal synaptic plasticity. Proceedings of 797 
the National Academy of Sciences of the United States of America 2004; 101:9458-798 
9462 799 
106. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, 800 
Rueger MA, Bae SK, Kittappa R, McKay RD. Notch signalling regulates stem cell 801 
numbers in vitro and in vivo. Nature 2006; 442:823-826 802 
107. Prochiantz A, Theodore L. Nuclear/growth factors. BioEssays : news and reviews in 803 
molecular, cellular and developmental biology 1995; 17:39-44 804 
108. Fagiolini M, Fritschy JM, Low K, Mohler H, Rudolph U, Hensch TK. Specific 805 
GABAA circuits for visual cortical plasticity. Science 2004; 303:1681-1683 806 
109. Sugiyama S, Di Nardo AA, Aizawa S, Matsuo I, Volovitch M, Prochiantz A, Hensch 807 
TK. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex 808 
activates postnatal plasticity. Cell 2008; 134:508-520 809 
110. Wade A, McKinney A, Phillips JJ. Matrix regulators in neural stem cell functions. 810 
Biochimica et biophysica acta 2014; 1840:2520-2525 811 
111. Altman J, Das GD. Autoradiographic and histological evidence of postnatal 812 
hippocampal neurogenesis in rats. The Journal of comparative neurology 1965; 813 
124:319-335 814 
112. Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic analysis of 815 
light radioautographs. Science 1977; 197:1092-1094 816 
113. Ziegler AN, Levison SW, Wood TL. Insulin and IGF receptor signalling in neural-817 
stem-cell homeostasis. Nature reviews Endocrinology 2014;  818 
114. Blurton-Jones M, Kuan PN, Tuszynski MH. Anatomical evidence for transsynaptic 819 
influences of estrogen on brain-derived neurotrophic factor expression. The Journal of 820 
comparative neurology 2004; 468:347-360 821 
115. Galea LA, Spritzer MD, Barker JM, Pawluski JL. Gonadal hormone modulation of 822 
hippocampal neurogenesis in the adult. Hippocampus 2006; 16:225-232 823 
116. Perez-Martin M, Azcoitia I, Trejo JL, Sierra A, Garcia-Segura LM. An antagonist of 824 
estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth 825 
 26 
factor-I in the dentate gyrus of adult female rat. The European journal of neuroscience 826 
2003; 18:923-930 827 
117. Clemett DA, Punhani T, Duxon MS, Blackburn TP, Fone KC. Immunohistochemical 828 
localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 2000; 829 
39:123-132 830 
118. Banasr M, Hery M, Printemps R, Daszuta A. Serotonin-induced increases in adult cell 831 
proliferation and neurogenesis are mediated through different and common 5-HT 832 
receptor subtypes in the dentate gyrus and the subventricular zone. 833 
Neuropsychopharmacology : official publication of the American College of 834 
Neuropsychopharmacology 2004; 29:450-460 835 
119. Alenina N, Klempin F. The role of serotonin in adult hippocampal neurogenesis. 836 
Behavioural brain research 2015; 277C:49-57 837 
120. Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate 838 
gyrus and the subventricular zone of adult rats. Neuroscience 1999; 89:999-1002 839 
121. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment 840 
increases neurogenesis in adult rat hippocampus. The Journal of neuroscience : the 841 
official journal of the Society for Neuroscience 2000; 20:9104-9110 842 
122. Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel 843 
theory of depression. Molecular psychiatry 2000; 5:262-269 844 
123. Banasr M, Hery M, Brezun JM, Daszuta A. Serotonin mediates oestrogen stimulation 845 
of cell proliferation in the adult dentate gyrus. The European journal of neuroscience 846 
2001; 14:1417-1424 847 
124. Klempin F, Beis D, Mosienko V, Kempermann G, Bader M, Alenina N. Serotonin is 848 
required for exercise-induced adult hippocampal neurogenesis. The Journal of 849 
neuroscience : the official journal of the Society for Neuroscience 2013; 33:8270-8275 850 
125. Freund TF, Antal M. GABA-containing neurons in the septum control inhibitory 851 
interneurons in the hippocampus. Nature 1988; 336:170-173 852 
126. Hajos M, Hoffmann WE, Weaver RJ. Regulation of septo-hippocampal activity by 5-853 
hydroxytryptamine(2C) receptors. The Journal of pharmacology and experimental 854 
therapeutics 2003; 306:605-615 855 
127. Bellocchio EE, Reimer RJ, Fremeau RT, Jr., Edwards RH. Uptake of glutamate into 856 
synaptic vesicles by an inorganic phosphate transporter. Science 2000; 289:957-960 857 
128. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and 858 
characterization of the vesicular GABA transporter. Nature 1997; 389:870-876 859 
129. Fremeau RT, Jr., Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, 860 
Chaudhry FA, Nicoll RA, Edwards RH. Vesicular glutamate transporters 1 and 2 861 
target to functionally distinct synaptic release sites. Science 2004; 304:1815-1819 862 
130. Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N, Rhee 863 
JS. A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron 864 
2006; 50:575-587 865 
131. Conti F, Zuccarello LV, Barbaresi P, Minelli A, Brecha NC, Melone M. Neuronal, 866 
glial, and epithelial localization of gamma-aminobutyric acid transporter 2, a high-867 
affinity gamma-aminobutyric acid plasma membrane transporter, in the cerebral 868 
cortex and neighboring structures. The Journal of comparative neurology 1999; 869 
409:482-494 870 
132. Zhou Y, Holmseth S, Guo C, Hassel B, Hofner G, Huitfeldt HS, Wanner KT, Danbolt 871 
NC. Deletion of the gamma-aminobutyric acid transporter 2 (GAT2 and SLC6A13) 872 
gene in mice leads to changes in liver and brain taurine contents. The Journal of 873 
biological chemistry 2012; 287:35733-35746 874 
 27 
133. McCrossan ZA, Abbott GW. The MinK-related peptides. Neuropharmacology 2004; 875 
47:787-821 876 
134. Ying SW, Kanda VA, Hu Z, Purtell K, King EC, Abbott GW, Goldstein PA. Targeted 877 
deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits. 878 
PloS one 2012; 7:e42756 879 
135. Kundu P, Ciobotaru A, Foroughi S, Toro L, Stefani E, Eghbali M. Hormonal 880 
regulation of cardiac KCNE2 gene expression. Molecular and cellular endocrinology 881 
2008; 292:50-62 882 
136. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: from 883 
molecules to physiological function. Annual review of physiology 2003; 65:453-480 884 
137. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from 885 
molecular mechanisms to therapeutic opportunities. Antioxidants & redox signaling 886 
2011; 15:1957-1997 887 
138. Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and 888 
phenolic compounds are independent from their estrogenic properties. Proceedings of 889 
the National Academy of Sciences of the United States of America 1999; 96:8867-890 
8872 891 
139. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, Simpkins JW. 892 
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proceedings 893 
of the National Academy of Sciences of the United States of America 2003; 894 
100:11741-11746 895 
 896 
897 
 28 
Tables and Figures with Legends 898 
Table 1 Lists of top E2 target genes in the hippocampus of middle-aged OVX rats 899 
 900 
 901 
Microarray analysis identified 156 E2-regulated genes. Expression of nine genes increased more than 902 
10-fold, and these were named prime target genes. Expression of twelve genes increased more that 4-903 
fold but less than 10-fold, these were called substantial target genes. Probeset ID, code of Affymetrix 904 
Rat 230 Expression Array probeset; FC, fold change; p adj, adjusted p value. 905 
906 
probeset ID logFC FC p adj symbol gene name
1367598_PM_at 5,786 55,166 0,013 Ttr transthyretin
1369361_PM_at 5,000 32,011 0,000 Kl Klotho
1375933_PM_at 4,961 31,148 0,001 Cldn2 claudin 2
1370789_PM_a_at 4,881 29,468 0,001 Prlr prolactin receptor
1379281_PM_at 4,848 28,794 0,000 Sostdc1 ectodin/wise
1374320_PM_at 3,915 15,082 0,000 F5 coagulation factor V
1367571_PM_a_at 3,591 12,054 0,002 Igf2 insulin-like growth factor 2
1367648_PM_at 3,439 10,845 0,001 Igfbp2 igf binding protein 2
1390532_PM_at 3,420 10,705 0,001 Slc13a4 sodium/sulfate symporters
1387889_PM_at 3,098 8,562 0,016 Folr1 folate receptor 1 (adult)
1387854_PM_at 2,927 7,605 0,001 Col1a2 collagen, type I, alpha 2
1376980_PM_at 2,783 6,885 0,011 Htr2c 5-HT receptor 2C
1383266_PM_at 2,607 6,092 0,081 Sfrp1 secreted frizzled-related
1374172_PM_at 2,379 5,202 0,248 Col8a2 collagen, type VIII, alpha 2
1377434_PM_at 2,358 5,128 0,164 Mfrp membrane frizzled-related
1370959_PM_at 2,287 4,882 0,005 Col3a1 collagen, type III, alpha 1
1375465_PM_at 2,267 4,812 0,154 Otx2 orthodenticle homeobox 2
1387791_PM_at 2,139 4,404 0,029 Ace angiotensin converting enz
1367682_PM_at 2,063 4,180 0,108 Mdk midkine
1368536_PM_at 2,046 4,128 0,000 Enpp2 ectonuc pyrophosphatase
1388116_PM-at 2,019 4,052 0,155 Col1a1 collagen, type I, alpha 1
PRIME TARGET GENES
SUBSTANTIAL TARGET GENES
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Table 2 Comparison of PCR and microarray data on hippocampal gene expression 907 
 908 
 909 
Expression of selected genes was determined in the hippocampus of middle-aged OVX rats treated 910 
either with vehicle (OVX) or E2 (OVX+E2) by quantitative real-time PCR. Comparison of PCR 911 
results with microarray data showed high similarity which provides a strong confirmation of the 912 
microarray data. Relative quantity (RQ=2
-Ct
) was used to characterize expression of a given gene in 913 
Assay ID symbol RQ p FC p adj
Rn00562124_m1 Ttr 15,99 0,008 55,16 0,013
Rn00580123_m1 Kl 14,90 0,006 32,01 0,000
Rn02063575_s1 Cldn2 11,86 0,021 31,15 0,001
Rn01525459_m1 Prlr 35,22 0,000 29,47 0,001
Rn00596672_m1 Sostdc1 13,49 0,006 28,79 0,000
Rn01454518_m1 Igf2 7,474 0,017 12,05 0,002
Rn00565473_m1 Igfbp2 9,807 0,004 10,85 0,001
Rn01747911_m1 Slc13a4 7,210 0,001 10,71 0,001
Rn00591759_m1 Folr1 7,144 0,005 8,562 0,016
Rn00562748_m1 Htr2c 6,750 0,003 6,885 0,011
Rn01478472_m1 Sfrp1 5,926 0,002 6,092 0,081
Rn01414596_m1 Otx2 13,31 0,003 4,812 0,154
Rn00561094_m1 Ace 6,469 0,006 4,404 0,029
Rn00675549_g1 Mdk 4,573 0,003 4,180 0,108
Rn01505088_m1 Enpp2 4,749 0,003 4,128 0,000
Rn01463516_m1 Slco1a5 18,68 0,001 3,791 0,231
Rn01502044_g1 Cdkn1c 3,777 0,006 3,787 0,005
Rn00564605_m1 Ptgds 3,016 0,000 3,256 0,166
Rn02094913_s1 Kcne2 3,722 0,023 3,239 0,588
Rn00667535_m1 Msx1 3,152 0,003 2,801 0,200
Rn00592456_m1 Slc6a13 2,955 0,000 2,784 0,040
Rn00560589_m1 A2m 3,480 0,000 2,611 0,204
Rn00571516_m1 Anxa2 3,254 0,001 2,542 0,081
Rn00562834_m1 Aqp1 11,31 0,008 2,478 0,110
Rn01487342_m1 Mrc1 1,959 0,004 2,357 0,152
Rn00562884_m1 Cox8b 3,252 0,024 2,224 0,341
Rn01427989_s1 Cdkn1a 2,103 0,001 2,197 0,464
Rn00563570_m1 Sod3 1,874 0,002 2,081 0,089
Rn00568361_m1 Crabp2 1,999 0,004 1,942 0,407
Rn00588079_m1 Aldh1a2 3,651 0,000 1,902 0,155
Rn00710306_m1 Igf1 4,018 0,000 1,672 0,501
Rn00710727_m1 Rdh10 1,364 0,006 1,654 0,161
Rn00577994_g1 Gpx1 1,653 0,000 1,619 0,205
Rn00575617_m1 Crhr2 11,418 0,001
Rn01537468_g1 Sgk1 1,508 0,021
Rn00582505_m1 Slc12a2 1,75 0,001
Rn00587830_m1 Slc17a7 0,59 0,001
Rn00824654_m1 Slc32a1 0,66 0,001
MICROARRAYREAL-TIME PCR
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E2 treated animals compared to controls and was determined from seven independent experiments. 914 
One-way ANOVA identified statistically significant (p<0.05) changes for all genes. P, p value. 915 
916 
 31 
Legends to figures 917 
Figure 1. Heat map depicting top 25 differentially expressed genes in the hippocampus of  918 
middle-aged ovariectomized (OVX) and middle-aged ovariectomized rats treated with E2 (OVX+E2). 919 
On the left, four columns represent expression data from vehicle-treated rats, four columns on the right 920 
show data from E2-replaced animals. In general, weakly expressed genes became moderately 921 
expressed. The two exceptions included transthyretin (Ttr) and autotaxin (Enpp2), they became 922 
abundantly expressed. Downregulated genes were weakly transcribed.  923 
Figure 2. Classification of one hundred fifty-six genes revealed nine functional groups. These 924 
groups include cell adhesion, cytoskeleton, ECM, immune, metabolism, miscellaneous, signaling, 925 
transporter and transcription. Major functional groups are signaling and metabolism containing thirty-926 
five and thirty-one genes, respectively. 927 
Figure 3. Schematic illustration of the E2 fingerprint on the hippocampal transcriptome of the 928 
middle-aged ovariectomized female rat. E2 modifies gene expression of most cellular constituents of 929 
the hippocampal formation resulting in changes in neurogenesis, synaptic plasticity and 930 
neuroprotection as evidenced in the literature. The most widely characterized regulatory mechanisms 931 
of the hippocampus involving the corresponding target genes are depicted in the left and right columns 932 
of the scheme. CA1-CA3, sector 1-3 of Cornu Ammonis; DG, dentate gyrus.  933 
 934 
935 
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Figure 1 936 
 937 
 938 
  939 
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Figure 2 940 
 941 
 942 
  943 
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Figure 3 944 
 945 
 946 
  947 
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SUPPLEMENTUM 948 
Supplemental Table 1  The list of E2-regulated genes in decreasing order 949 
 950 
probeset ID logFC FC adj. P symbol gene name
1367598_PM_at 5,786 55,166 0,013 Ttr transthyretin
1369361_PM_at 5,000 32,011 0,000 Kl Klotho
1375933_PM_at 4,961 31,148 0,001 Cldn2 claudin 2
1370789_PM_a_at 4,881 29,468 0,001 Prlr prolactin receptor
1379281_PM_at 4,848 28,794 0,000 Sostdc1 sclerostin domain containing 1
1374320_PM_at 3,915 15,082 0,000 F5 coagulation factor V
1367571_PM_a_at 3,591 12,054 0,002 Igf2 insulin-like growth factor 2
1367648_PM_at 3,439 10,845 0,001 Igfbp2 igf binding protein 2
1390532_PM_at 3,420 10,705 0,001 Slc13a4 sodium/sulfate symporters
1387889_PM_at 3,098 8,562 0,016 Folr1 folate receptor 1 (adult)
1387854_PM_at 2,927 7,605 0,001 Col1a2 collagen, type I, alpha 2
1376980_PM_at 2,783 6,885 0,011 Htr2c 5-HT receptor 2C
1383266_PM_at 2,607 6,092 0,081 Sfrp1 secreted frizzled-related protein
1374172_PM_at 2,379 5,202 0,248 Col8a2 collagen, type VIII, alpha 2
1377434_PM_at 2,358 5,128 0,164 Mfrp membrane frizzled-related protein
1370959_PM_at 2,287 4,882 0,005 Col3a1 collagen, type III, alpha 1
1375465_PM_at 2,267 4,812 0,154 Otx2 orthodenticle homeobox 2
1387791_PM_at 2,139 4,404 0,029 Ace angiotensin converting enzyme
1367682_PM_at 2,063 4,180 0,108 Mdk midkine
1368536_PM_at 2,046 4,128 0,000 Enpp2 ectonucleotide pyrophosphatase
1388116_PM_at 2,019 4,052 0,155 Col1a1 collagen, type I, alpha 1
1369705_PM_at 1,928 3,805 0,001 Slc6a20 solute carrier family 6, member 20
1368606_PM_at 1,923 3,791 0,231 Slco1a5 sol carrier organic anion transporter family, member 1a5
1372299_PM_at 1,921 3,787 0,005 Cdkn1c cyclin-dependent kinase inhibitor 1C
1389107_PM_at 1,909 3,755 0,040 Cgnl1 cingulin-like 1
1385248_PM_a_at 1,817 3,523 0,005 Ogn osteoglycin
1367851_PM_at 1,703 3,256 0,166 Ptgds prostaglandin D2 synthase (brain)
1394343_PM_s_at 1,696 3,239 0,588 Kcne2 K+ channel, Isk-related family
1370301_PM_at 1,521 2,870 0,164 Mmp2 matrix metallopeptidase 2
1393436_PM_at 1,520 2,869 0,662 Scgb1c1 secretoglobin, family 1C, member 1
1368302_PM_at 1,486 2,801 0,200 Msx1 msh homeobox 1
1387372_PM_at 1,477 2,784 0,040 Slc6a13 neurotransmitter transporter, GABA
1368337_PM_at 1,462 2,754 0,036 Glycam1 glycosylation dependent CAM 1
1367794_PM_at 1,385 2,611 0,204 A2m alpha-2-macroglobulin
1367584_PM_at 1,346 2,542 0,081 Anxa2 annexin A2
1390404_PM_at 1,332 2,517 0,253 Lama2 laminin, alpha 2
1370956_PM_at 1,319 2,494 0,002 Dcn decorin
1369625_PM_at 1,309 2,478 0,110 Aqp1 aquaporin 1
1371849_PM_at 1,278 2,425 0,081 Nt5dc2 5'-nucleotidase domain containing 2
1389251_PM_at 1,269 2,410 0,361 Nudt7 nudix (nucleoside diphosphate linked moietyX)-type motif 7
1377034_PM_at 1,243 2,366 0,262 Serpinb1a serine/cysteine proteinase inhibitor, clade B, member 1a
1376861_PM_at 1,241 2,364 0,164 Mospd1 motile sperm domain containing 1
1392648_PM_at 1,237 2,357 0,152 Mrc1 mannose receptor, C type 1
1367568_PM_a_at 1,208 2,309 0,078 Mgp matrix Gla protein
1367739_PM_at 1,153 2,224 0,341 Cox8b cytochrome c oxidase, subunit VIIIb
1368202_PM_a_at 1,151 2,221 0,141 Dab2 disabled homolog 2 (Drosophila)
1371369_PM_at 1,136 2,198 0,441 Col6a2 collagen, type VI, alpha 2
 36 
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 952 
953 
1388674_PM_at 1,136 2,197 0,464 Cdkn1a cyclin-dependent kinase inhibitor 1A
1387013_PM_at 1,130 2,189 0,656 Tmem27 transmembrane protein 27
1367749_PM_at 1,129 2,186 0,078 Lum lumican
1368082_PM_at 1,123 2,178 0,204 Slc4a2 solute carrier family 4, member 2
1372064_PM_at 1,118 2,170 0,108 Cxcl16 chemokine (C-X-C motif) ligand 16
1387122_PM_at 1,112 2,162 0,204 Plagl1 pleiomorphic adenoma gene-like 1
1370538_PM_at 1,096 2,137 0,606 Lama3 laminin, alpha 3
1373386_PM_at 1,095 2,136 0,498 Gjb2 gap junction protein, beta 2
1389836_PM_a_at 1,082 2,116 0,012 Timp3 TIMP metallopeptidase inhibitor 3
1368046_PM_at 1,070 2,100 0,309 Slc31a1 solute carrier family 31, member 1
1368322_PM_at 1,057 2,081 0,089 Sod3 superoxide dismutase 3, extracellular
1377790_PM_at 1,048 2,068 0,318 Rab11fip1 RAB11 family interacting protein 1
1372426_PM_at 1,033 2,046 0,408 Adamtsl4 ADAMTS-like 4
1393706_PM_at 1,000 2,000 0,643 Steap1 six transmembrane epithelial antigen
1382083_PM_at 0,992 1,989 0,204 Coch coagulation factor C homolog, cochlin
1374139_PM_at 0,992 1,989 0,559 Cdr2 cerebellar degeneration-related 2
1374752_PM_at 0,983 1,977 0,511 Mdfic MyoD family inhibitor domain contain
1372297_PM_at 0,967 1,954 0,443 Gsta4 glutathione S-transferase alpha 4
1370391_PM_at 0,958 1,942 0,407 Crabp2 cellular retinoic acid binding protein 2
1370875_PM_at 0,949 1,930 0,129 Ezr ezrin
1388557_PM_at 0,946 1,926 0,164 Tubb4b tubulin, beta 4B class IVb
1380596_PM_at 0,931 1,907 0,204 Dsg2 desmoglein 2
1378753_PM_at 0,931 1,906 0,575 Ocln occludin
1368003_PM_at 0,928 1,902 0,155 Aldh1a2 aldehyde dehydrogenase 1 family
1388320_PM_at 0,923 1,895 0,253 Spint2 Kunitz type serine peptidase inhibitor
1387946_PM_at 0,915 1,885 0,566 Lgals3bp lectin, galactoside-binding, soluble
1372818_PM_at 0,893 1,857 0,017 Colec12 collectin sub-family member 12
1388183_PM_at 0,890 1,853 0,802 Csn1s1 casein alpha s1
1369943_PM_at 0,877 1,836 0,040 Tgm2 transglutaminase 2, C polypeptide
1370857_PM_at 0,867 1,824 0,121 Acta2 smooth muscle alpha-actin
1370068_PM_at 0,863 1,819 0,505 Pla2g5 phospholipase A2, group V
1367594_PM_at 0,854 1,807 0,149 Bgn biglycan
1387053_PM_at 0,850 1,802 0,161 Fmo1 flavin containing monooxygenase 1
1368822_PM_at 0,837 1,786 0,218 Fstl1 follistatin-like 1
1389617_PM_at 0,834 1,782 0,743 Elk3 ELK3, ETS-domain protein
1383895_PM_at 0,832 1,780 0,108 Dynlrb2 dynein light chain roadblock-type 2
1396150_PM_at 0,828 1,775 0,639 Cldn1 claudin 1
1377631_PM_at 0,813 1,757 0,443 Col9a3 procollagen, type IX, alpha 3
1387886_PM_at 0,802 1,743 0,049 Prelp proline/arginine-rich end leucine-rich
1398484_PM_at 0,795 1,735 0,253 Tbc1d9 TBC1 domain family, member 9
1390989_PM_at 0,795 1,735 0,345 Mospd2 motile sperm domain containing 2
1398383_PM_at 0,791 1,730 0,262 Cyb561 cytochrome b-561
1368725_PM_at 0,783 1,720 0,638 Jag1 jagged 1
1382171_PM_at 0,779 1,716 0,805 Tsc22d2 TSC22 domain family, member 2
1370154_PM_at 0,779 1,715 0,082 Lyz2 lysozyme 2
1376200_PM_at 0,778 1,715 0,271 Mettl20 methyltransferase like 20
1371960_PM_at 0,771 1,706 0,402 Ythdf2 YTH domain family, member 2
1374743_PM_at 0,766 1,701 0,004 Inadl2 InaD-like 2 (Drosophila)
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1371847_PM_at 0,761 1,695 0,684 Crtap cartilage associated protein
1370952_PM_at 0,760 1,694 0,515 Gstm2 glutathione S-transferase mu 2
1390937_PM_at 0,759 1,692 0,212 Ppp1r36 protein phosphatase 1, regulatory subunit 36
1367631_PM_at 0,758 1,691 0,049 Ctgf connective tissue growth factor
1370333_PM_a_at 0,741 1,672 0,501 Igf1 insulin-like growth factor 1
1375026_PM_at 0,739 1,669 0,737 Calml4 calmodulin-like 4
1387111_PM_at 0,734 1,663 0,649 Ddah1 dimethylarginine dimethylaminohydrolase 1
1379352_PM_at 0,731 1,660 0,156 Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type I, beta
1390715_PM_at 0,729 1,657 0,490 Igfbpl1 insulin-like growth factor binding protein-like 1
1393351_PM_at 0,726 1,654 0,161 Rdh10 retinol dehydrogenase 10 (all-trans)
1368223_PM_at 0,726 1,654 0,082 Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1
1371518_PM_at 0,722 1,649 0,372 Nid1 nidogen 1
1372726_PM_at 0,713 1,639 0,495 Hist1h4b histone cluster 1, H4b
1390912_PM_at 0,705 1,631 0,506 Pcp4l1 Purkinje cell protein 4-like 1
1388654_PM_at 0,702 1,627 0,230 Mrpl52 mitochondrial ribosomal protein L52
1370750_PM_a_at 0,700 1,625 0,219 Il1r1 interleukin 1 receptor, type I
1369524_PM_at 0,698 1,622 0,154 Zic1 Zic family member 1
1367574_PM_at 0,697 1,621 0,311 Vim vimentin
1371762_PM_at 0,695 1,619 0,480 Rbp4 retinol binding protein 4, plasma
1367576_PM_at 0,695 1,619 0,205 Gpx1 glutathione peroxidase 1
1387484_PM_at 0,692 1,616 0,418 Tgfbr3 transforming growth factor, beta receptor III
1367960_PM_at 0,684 1,607 0,211 Arl4a ADP-ribosylation factor-like 4A
1383129_PM_at 0,680 1,602 0,612 Wls wntless homolog (Drosophila)
1377721_PM_at 0,678 1,600 0,501 Pacrg Park2 co-regulated
1387995_PM_a_at 0,677 1,599 0,513 Ifitm3 interferon induced transmembrane p
1375892_PM_at 0,676 1,598 0,780 Elavl1 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1
1369020_PM_at 0,675 1,597 0,441 Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5
1367765_PM_at 0,673 1,594 0,273 Tcn2 transcobalamin 2
1392677_PM_at 0,669 1,589 0,204 Zic4 Zic family member 4
1393605_PM_at 0,660 1,580 0,328 Vav3 vav 3 guanine nucleotide exchange f
1379483_PM_at 0,658 1,578 0,850 Bhlhe40 basic helix-loop-helix family, member e40
1388762_PM_at 0,654 1,573 0,156 Iqgap1 IQ motif containing GTPase activating protein 1
1391262_PM_at 0,647 1,566 0,775 Senp5 Sumo1/sentrin/SMT3 specific peptidase 5
1388342_PM_at 0,645 1,564 0,868 Etv3 ets variant 3
1379868_PM_at 0,640 1,558 0,657 Pbxip1 pre-B-cell leukemia homeobox interacting protein 1
1373790_PM_at 0,638 1,556 0,345 Car14 carbonic anhydrase 14
1367860_PM_a_at 0,632 1,550 0,313 Mmp14 matrix metallopeptidase 14
1371880_PM_at 0,628 1,545 0,775 Sp1 Sp1 transcription factor
1370907_PM_at 0,628 1,545 0,205 St6gal1 ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
1384591_PM_at 0,627 1,544 0,306 Pear1 platelet endothelial aggregation receptor 1
1394940_PM_at 0,626 1,544 0,566 Fam46a family with sequence similarity 46, member A
1371382_PM_at 0,624 1,541 0,239 Flna filamin A, alpha
1398362_PM_at 0,614 1,531 0,441 Notch2 notch 2
1372905_PM_at 0,611 1,527 0,814 Vcl vinculin
1371954_PM_at 0,606 1,522 0,642 Tns1 tensin 1
1369970_PM_at 0,603 1,519 0,269 Vamp8 vesicle-associated membrane protein 8
1375215_PM_x_at 0,601 1,517 0,779 Pgpep1 pyroglutamyl-peptidase I
1387059_PM_at 0,599 1,514 0,449 Stk39 serine threonine kinase 39
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In data analysis we applied the standard selection criterion of absolute FC>1.5. Affymetrix probeset 958 
ID, logFC, FC, adjusted p value, gene symbol and name are displayed. 959 
 960 
  961 
1367939_PM_at 0,597 1,513 0,164 Rbp1 retinol binding protein 1, cellular
1373122_PM_at 0,595 1,511 0,219 Ajuba ajuba LIM protein
1396109_PM_at 0,595 1,511 0,649 Antxr1 anthrax toxin receptor 1
1395036_PM_at 0,594 1,510 0,608 Impad1 inositol monophosphatase domain containing 1
1390525_PM_a_at 0,593 1,509 0,600 Stra6 stimulated by retinoic acid gene 6
1369959_PM_at 0,592 1,508 0,468 Zfp36l1 zinc finger protein 36, C3H type-like 1
1390464_PM_at 0,591 1,506 0,863 Frmd4b FERM domain containing 4B
1390863_PM_at 0,590 1,505 0,570 Slc19a2 solute carrier family 19 (thiamine transporter), member 2
1370941_PM_at 0,589 1,504 0,110 Pdgfra platelet derived growth factor receptor, alpha polypeptide
1368585_PM_at -0,583 0,667 0,509 Cartpt CART prepropeptide
1389533_PM_at -0,615 0,653 0,398 Fbln2 fibulin 2
1372195_PM_at -0,667 0,630 0,779 Tnnc2 troponin C type 2 (fast)
1393795_PM_at -0,733 0,602 0,862 Zeb2 zinc finger E-box binding homeobox 2
 40 
Supplemental Table 2  Clusters of E2 regulated genes identified by functional annotation 962 
 963 
 964 
 965 
 966 
DAVID Functional Annotation Clustering Tool (http://david.abcc.ncifcrf.gov) was used for functional 967 
annotation clustering of the 156 genes regulated by E2 at high stringency. P, adjusted p value; ES, 968 
enrichment score. 969 
 970 
  971 
CLUSTER p ES GENES
1 Response to hormones 4.230
response to steroid hormone 0.002
response to hormone stimulus 0.012
response to endogenous stimulus 0.024
2 Pattern binding 3.950
glycosaminoglycan binding 0.004
pattern binding 0.006
polysaccharide binding 0.006
heparin binding 0.010
3 Cell motility 3.726
regulation of locomotion 0.009
regulation of cell migration 0.011
regulation of cell motion 0.020
4 Development 3.368
lung development 0.020
5 Retinoid 3.195
vitamin A 0.001
retinoid binding 0.007
isoprenoid binding 0.010
retinol binding 0.050
6 Collagen 2.085
fibrillar collagen 0.013
collagen 0.050
Aldh1a2, Rbp2, Ptgds, Rbp1, Rbp4, Ttr
Anxa2, Col1a1, Col1a2, Col3a1, Clcn12, 
Lum
Timp3, Aldh1a2, A2m, Aqp1, Col1a1, 
Cdkn1a, Gpx1, Igf1, Igf2, Igfbp2, Mgp, 
Mmp14, Mdk, Pdgfra, Ptgds, Rbp4
Adamtsl4, Bgn, Cln12, Ctgt, Dcn, Flstl1, 
Mrc1, Mdk, Pla2, Tgfbr3
Htr2c, Ace, Cxcl16, Enpp2, Igf1, Jub, 
Lama2, Lama3, Pdgfra, Tgfbr3, Vcn
Sp1, Aldh1a2, Ctgf, Mgp, Mmp14, Pdgfra, 
Rbp4, Rdh10
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Supplemental Table 3  Correlation analysis of prime E2 target genes.  972 
 973 
 974 
Real-time PCR data from eight independent experiments were analyzed by the Statistica software. The 975 
correlation coefficient (R) matrix showed great variations in R values. Strong association (R>0.98) 976 
was revealed in case of Igf2-Igfbp2, Sostdc1-Slc13a4, Igf2-Ttr, Ttr-Igfbp2 and Prlr-Sostdc1. 977 
 978 
  979 
Ttr Kl Cldn2 Prlr Sostdc1 Igf2 Igfbp2 Slc13a4
Ttr 0,962 0,572 0,924 0,959 0,991 0,987 0,964
Kl 0,962 0,569 0,859 0,894 0,970 0,962 0,911
Cldn2 0,572 0,569 0,637 0,625 0,550 0,560 0,590
Prlr 0,924 0,859 0,637 0,981 0,918 0,910 0,976
Sostdc1 0,959 0,894 0,625 0,981 0,950 0,952 0,992
Igf2 0,991 0,970 0,550 0,918 0,950 0,995 0,961
Igfbp2 0,987 0,962 0,560 0,910 0,952 0,995 0,955
Slc13a4 0,964 0,911 0,590 0,976 0,992 0,961 0,955
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Supplemental Table 4  List of abbreviations 980 
 981 
982 
symbol gene name
A2m alpha-2-macroglobulin
Ace angiotensin converting enzyme
Acta2 smooth muscle alpha-actin
Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1
Adamtsl4 ADAMTS-like 4
Ajuba ajuba LIM protein
Aldh1a2 aldehyde dehydrogenase 1 family
Antxr1 anthrax toxin receptor 1
Anxa2 annexin A2
Aqp1 aquaporin 1
Arl4a ADP-ribosylation factor-like 4A
Bgn biglycan
Bhlhe40 basic helix-loop-helix family, member e40
Calml4 calmodulin-like 4
Car14 carbonic anhydrase 14
Cartpt CART prepropeptide
Cdkn1a cyclin-dependent kinase inhibitor 1A
Cdkn1c cyclin-dependent kinase inhibitor 1C
Cdr2 cerebellar degeneration-related 2
Cgnl1 cingulin-like 1
Cldn1 claudin 1
Cldn2 claudin 2
Coch coagulation factor C homolog, cochlin
Col1a1 collagen, type I, alpha 1
Col1a2 collagen, type I, alpha 2
Col3a1 collagen, type III, alpha 1
Col6a2 collagen, type VI, alpha 2
Col8a2 collagen, type VIII, alpha 2
Col9a3 procollagen, type IX, alpha 3
Colec12 collectin sub-family member 12
Cox8b cytochrome c oxidase, subunit VIIIb
Crabp2 cellular retinoic acid binding protein 2
Crtap cartilage associated protein
Ctgf connective tissue growth factor
Cxcl16 chemokine (C-X-C motif) ligand 16
Cyb561 cytochrome b-561
Csn1s1 casein alpha s1
Dab2 disabled homolog 2 (Drosophila)
Dcn decorin
Ddah1 dimethylarginine dimethylaminohydrolase 1
Dsg2 desmoglein 2
Dynlrb2 dynein light chain roadblock-type 2
Elavl1 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1
Elk3 ELK3, ETS-domain protein
Enpp2 ectonucleotide pyrophosphatase
Etv3 ets variant 3
Ezr ezrin
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F5 coagulation factor V
Fam46a family with sequence similarity 46, member A
Fbln2 fibulin 2
Flna filamin A, alpha
Fmo1 flavin containing monooxygenase 1
Folr1 folate receptor 1 (adult)
Frmd4b FERM domain containing 4B
Fstl1 follistatin-like 1
Gjb2 gap junction protein, beta 2
Glycam1 glycosylation dependent CAM 1
Gpx1 glutathione peroxidase 1
Gsta4 glutathione S-transferase alpha 4
Gstm2 glutathione S-transferase mu 2
Hist1h4b histone cluster 1, H4b
Htr2c 5-HT receptor 2C
Ifitm3 interferon induced transmembrane p
Igf1 insulin-like growth factor 1
Igf2 insulin-like growth factor 2
Igfbp2 igf binding protein 2
Igfbpl1 insulin-like growth factor binding protein-like 1
Il1r1 interleukin 1 receptor, type I
Impad1 inositol monophosphatase domain containing 1
Inadl2 InaD-like 2 (Drosophila)
Iqgap1 IQ motif containing GTPase activating protein 1
Jag1 jagged 1
Kcne2 K+ channel, Isk-related family
Kl Klotho
Lama2 laminin, alpha 2
Lama3 laminin, alpha 3
Lgals3bp lectin, galactoside-binding, soluble
Lum lumican
Lyz2 lysozyme 2
Mdfic MyoD family inhibitor domain contain
Mdk midkine
Mettl20 methyltransferase like 20
Mfrp membrane frizzled-related protein
Mgp matrix Gla protein
Mmp14 matrix metallopeptidase 14
Mmp2 matrix metallopeptidase 2
Mospd1 motile sperm domain containing 1
Mospd2 motile sperm domain containing 2
Mrc1 mannose receptor, C type 1
Mrpl52 mitochondrial ribosomal protein L52
Msx1 msh homeobox 1
Nid1 nidogen 1
Notch2 notch 2
Nt5dc2 5'-nucleotidase domain containing 2
Nudt7 nudix (nucleoside diphosphate linked moietyX)-type motif 7
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Ocln occludin
Ogn osteoglycin
Otx2 orthodenticle homeobox 2
Pacrg Park2 co-regulated
Pbxip1 pre-B-cell leukemia homeobox interacting protein 1
Pcp4l1 Purkinje cell protein 4-like 1
Pdgfra platelet derived growth factor receptor, alpha polypeptide
Pear1 platelet endothelial aggregation receptor 1
Pgpep1 pyroglutamyl-peptidase I
Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type I, beta
Pla2g5 phospholipase A2, group V
Plagl1 pleiomorphic adenoma gene-like 1
Ppp1r36 protein phosphatase 1, regulatory subunit 36
Prelp proline/arginine-rich end leucine-rich
Prlr prolactin receptor
Ptgds prostaglandin D2 synthase (brain)
Rab11fip1 RAB11 family interacting protein 1
Rbp1 retinol binding protein 1, cellular
Rbp4 retinol binding protein 4, plasma
Rdh10 retinol dehydrogenase 10 (all-trans)
Scgb1c1 secretoglobin, family 1C, member 1
Senp5 Sumo1/sentrin/SMT3 specific peptidase 5
Serpinb1a serine/cysteine proteinase inhibitor, clade B, member 1a
Sfrp1 secreted frizzled-related protein
Slc13a4 sodium/sulfate symporters
Slc19a2 solute carrier family 19 (thiamine transporter), member 2
Slc31a1 solute carrier family 31, member 1
Slc4a2 solute carrier family 4, member 2
Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5
Slc6a13 neurotransmitter transporter, GABA
Slc6a20 solute carrier family 6, member 20
Slco1a5 sol carrier organic anion transporter family, member 1a5
Sod3 superoxide dismutase 3, extracellular
Sostdc1 sclerostin domain containing 1
Sp1 Sp1 transcription factor
Spint2 Kunitz type serine peptidase inhibitor
St6gal1 ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
Steap1 six transmembrane epithelial antigen
Stk39 serine threonine kinase 39
Stra6 stimulated by retinoic acid gene 6
Tbc1d9 TBC1 domain family, member 9
Tcn2 transcobalamin 2
Tgfbr3 transforming growth factor, beta receptor III
Tgm2 transglutaminase 2, C polypeptide
Timp3 TIMP metallopeptidase inhibitor 3
Tmem27 transmembrane protein 27
Tnnc2 troponin C type 2 (fast)
Tns1 tensin 1
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Tsc22d2 TSC22 domain family, member 2
Ttr transthyretin
Tubb4b tubulin, beta 4B class IVb
Vamp8 vesicle-associated membrane protein 8
Vav3 vav 3 guanine nucleotide exchange f
Vcl vinculin
Vim vimentin
Wls wntless homolog (Drosophila)
Ythdf2 YTH domain family, member 2
Zeb2 zinc finger E-box binding homeobox 2
Zfp36l1 zinc finger protein 36, C3H type-like 1
Zic1 Zic family member 1
Zic4 Zic family member 4
